[{"USUBJID":"01-001","SITEID":"01","SITE":"Site 01","AGE":"30","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-16","STDY":"57","ENDT":"2015-08-14","ENDY":"86","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-001","SITEID":"01","SITE":"Site 01","AGE":"30","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-16","STDY":"57","ENDT":"2015-08-14","ENDY":"86","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-001","SITEID":"01","SITE":"Site 01","AGE":"30","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-21","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-21","STDY":"1","ENDT":"2015-05-21","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-001","SITEID":"01","SITE":"Site 01","AGE":"30","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-21","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-17","STDY":"58","ENDT":"2015-07-17","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-001","SITEID":"01","SITE":"Site 01","AGE":"30","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-21","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-09","STDY":"355","ENDT":"2016-05-09","ENDY":"355","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-002","SITEID":"01","SITE":"Site 01","AGE":"24","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-02","STDY":"34","ENDT":"2015-07-16","ENDY":"48","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-002","SITEID":"01","SITE":"Site 01","AGE":"24","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-18","STDY":"173","ENDT":"2016-05-06","ENDY":"343","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-002","SITEID":"01","SITE":"Site 01","AGE":"24","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-27","STDY":"182","ENDT":"2016-05-02","ENDY":"339","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-002","SITEID":"01","SITE":"Site 01","AGE":"24","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-19","STDY":"204","ENDT":"2016-05-25","ENDY":"362","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-002","SITEID":"01","SITE":"Site 01","AGE":"24","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-23","STDY":"299","ENDT":"2016-04-12","ENDY":"319","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-002","SITEID":"01","SITE":"Site 01","AGE":"24","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-30","STDY":"1","ENDT":"2015-05-30","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-002","SITEID":"01","SITE":"Site 01","AGE":"24","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-29","STDY":"61","ENDT":"2015-07-29","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-002","SITEID":"01","SITE":"Site 01","AGE":"24","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-29","STDY":"366","ENDT":"2016-05-29","ENDY":"366","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-003","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-08-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-09-11","STDY":"29","ENDT":"2016-03-02","ENDY":"202","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-003","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-08-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-03","STDY":"143","ENDT":"2016-01-12","ENDY":"152","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-003","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-08-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-13","STDY":"305","ENDT":"2016-06-21","ENDY":"313","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-003","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-08-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-04","STDY":"113","ENDT":"2016-07-21","ENDY":"343","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-003","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-08-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-17","STDY":"126","ENDT":"2016-05-08","ENDY":"269","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-003","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-08-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-11","STDY":"182","ENDT":"2016-07-17","ENDY":"339","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-003","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-08-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-08-14","STDY":"1","ENDT":"2015-08-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-003","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-08-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-05","STDY":"53","ENDT":"2015-10-05","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-003","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-08-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-08-19","STDY":"372","ENDT":"2016-08-19","ENDY":"372","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-004","SITEID":"01","SITE":"Site 01","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-04","STDY":"173","ENDT":"2015-12-21","ENDY":"343","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-004","SITEID":"01","SITE":"Site 01","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-13","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-13","STDY":"1","ENDT":"2015-01-13","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-004","SITEID":"01","SITE":"Site 01","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-13","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-03-03","STDY":"50","ENDT":"2015-03-03","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-004","SITEID":"01","SITE":"Site 01","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-13","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-06","STDY":"359","ENDT":"2016-01-06","ENDY":"359","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-005","SITEID":"01","SITE":"Site 01","AGE":"30","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-07-31","STDY":"218","ENDT":"2016-11-15","ENDY":"325","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-005","SITEID":"01","SITE":"Site 01","AGE":"30","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-27","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-27","STDY":"1","ENDT":"2015-12-27","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-005","SITEID":"01","SITE":"Site 01","AGE":"30","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-27","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-02-16","STDY":"52","ENDT":"2016-02-16","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-005","SITEID":"01","SITE":"Site 01","AGE":"30","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-27","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2017-01-03","STDY":"374","ENDT":"2017-01-03","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-006","SITEID":"01","SITE":"Site 01","AGE":"23","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-05-12","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-05-12","STDY":"1","ENDT":"2015-05-12","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-007","SITEID":"01","SITE":"Site 01","AGE":"20","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-09-11","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-09-11","STDY":"1","ENDT":"2015-09-11","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-008","SITEID":"01","SITE":"Site 01","AGE":"29","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-02-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-21","STDY":"36","ENDT":"2015-05-12","ENDY":"88","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-008","SITEID":"01","SITE":"Site 01","AGE":"29","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-02-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-02-14","STDY":"1","ENDT":"2015-02-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-008","SITEID":"01","SITE":"Site 01","AGE":"29","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-02-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-05","STDY":"51","ENDT":"2015-04-05","ENDY":"51","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-008","SITEID":"01","SITE":"Site 01","AGE":"29","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-02-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-15","STDY":"367","ENDT":"2016-02-15","ENDY":"367","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-23","STDY":"63","ENDT":"2016-01-28","ENDY":"68","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-04","STDY":"75","ENDT":"2016-04-18","ENDY":"149","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-27","STDY":"127","ENDT":"2016-08-27","ENDY":"280","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-08-22","STDY":"275","ENDT":"2016-10-14","ENDY":"328","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-10-24","STDY":"338","ENDT":"2016-11-04","ENDY":"349","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-10","STDY":"81","ENDT":"2016-04-08","ENDY":"139","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-24","STDY":"95","ENDT":"2016-10-02","ENDY":"316","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-28","STDY":"220","ENDT":"2016-09-28","ENDY":"312","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-22","STDY":"1","ENDT":"2015-11-22","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-21","STDY":"61","ENDT":"2016-01-21","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-009","SITEID":"01","SITE":"Site 01","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-11-22","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-20","STDY":"365","ENDT":"2016-11-20","ENDY":"365","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-010","SITEID":"01","SITE":"Site 01","AGE":"35","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-01-07","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-07","STDY":"1","ENDT":"2015-01-07","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-010","SITEID":"01","SITE":"Site 01","AGE":"35","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-01-07","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-02-24","STDY":"49","ENDT":"2015-02-24","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-010","SITEID":"01","SITE":"Site 01","AGE":"35","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-01-07","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-01","STDY":"360","ENDT":"2016-01-01","ENDY":"360","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-011","SITEID":"01","SITE":"Site 01","AGE":"33","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-22","STDY":"80","ENDT":"2015-12-27","ENDY":"85","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-011","SITEID":"01","SITE":"Site 01","AGE":"33","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-04","STDY":"1","ENDT":"2015-10-04","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-011","SITEID":"01","SITE":"Site 01","AGE":"33","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-03","STDY":"61","ENDT":"2015-12-03","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-011","SITEID":"01","SITE":"Site 01","AGE":"33","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-08","STDY":"371","ENDT":"2016-10-08","ENDY":"371","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-012","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-24","STDY":"6","ENDT":"2015-05-06","ENDY":"18","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-012","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-15","STDY":"88","ENDT":"2016-02-10","ENDY":"298","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-012","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-17","STDY":"305","ENDT":"2016-02-25","ENDY":"313","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-012","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-19","STDY":"1","ENDT":"2015-04-19","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-012","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-06","STDY":"49","ENDT":"2015-06-06","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-012","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-22","STDY":"370","ENDT":"2016-04-22","ENDY":"370","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-013","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-15","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-01","STDY":"262","ENDT":"2016-04-05","ENDY":"266","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-013","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-15","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-09","STDY":"331","ENDT":"2016-06-29","ENDY":"351","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-013","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-15","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-05","STDY":"83","ENDT":"2015-12-19","ENDY":"158","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-013","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-15","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-14","STDY":"215","ENDT":"2016-05-20","ENDY":"311","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-013","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-15","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-17","STDY":"247","ENDT":"2016-04-20","ENDY":"281","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-013","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-15","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-07-15","STDY":"1","ENDT":"2015-07-15","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-013","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-15","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-09-10","STDY":"58","ENDT":"2015-09-10","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-013","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-15","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-07-07","STDY":"359","ENDT":"2016-07-07","ENDY":"359","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-27","STDY":"150","ENDT":"2016-05-27","ENDY":"150","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-12","STDY":"166","ENDT":"2016-07-22","ENDY":"206","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-07-16","STDY":"200","ENDT":"2016-12-24","ENDY":"361","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-09-04","STDY":"250","ENDT":"2016-10-24","ENDY":"300","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-13","STDY":"75","ENDT":"2016-05-26","ENDY":"149","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-27","STDY":"150","ENDT":"2016-09-07","ENDY":"253","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-30","STDY":"214","ENDT":"2016-08-02","ENDY":"217","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-08-22","STDY":"237","ENDT":"2016-10-26","ENDY":"302","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-30","STDY":"1","ENDT":"2015-12-30","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-02-17","STDY":"50","ENDT":"2016-02-17","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-014","SITEID":"01","SITE":"Site 01","AGE":"32","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-30","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2017-01-07","STDY":"375","ENDT":"2017-01-07","ENDY":"375","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-015","SITEID":"01","SITE":"Site 01","AGE":"37","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-07-25","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-07-25","STDY":"1","ENDT":"2015-07-25","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-10","STDY":"52","ENDT":"2016-07-22","ENDY":"215","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-18","STDY":"89","ENDT":"2016-10-18","ENDY":"303","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-08","STDY":"110","ENDT":"2016-06-27","ENDY":"190","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-21","STDY":"32","ENDT":"2016-04-06","ENDY":"108","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-17","STDY":"88","ENDT":"2016-10-21","ENDY":"306","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-23","STDY":"125","ENDT":"2016-10-02","ENDY":"287","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-09-05","STDY":"260","ENDT":"2016-10-28","ENDY":"313","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-21","STDY":"1","ENDT":"2015-12-21","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-02-17","STDY":"59","ENDT":"2016-02-17","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-016","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-21","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-12-14","STDY":"360","ENDT":"2016-12-14","ENDY":"360","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-017","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-02-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-07","STDY":"85","ENDT":"2015-07-26","ENDY":"165","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-017","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-02-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-27","STDY":"258","ENDT":"2015-12-14","ENDY":"306","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-017","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-02-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-15","STDY":"277","ENDT":"2016-01-19","ENDY":"342","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-017","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-02-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-05-12","STDY":"90","ENDT":"2015-09-11","ENDY":"212","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-017","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-02-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-31","STDY":"262","ENDT":"2015-11-04","ENDY":"266","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-017","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-02-12","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-02-12","STDY":"1","ENDT":"2015-02-12","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-017","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-02-12","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-08","STDY":"56","ENDT":"2015-04-08","ENDY":"56","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-017","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-02-12","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-10","STDY":"364","ENDT":"2016-02-10","ENDY":"364","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-018","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-05","STDY":"24","ENDT":"2016-02-22","ENDY":"72","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-018","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-25","STDY":"104","ENDT":"2016-12-06","ENDY":"360","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-018","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-03","STDY":"174","ENDT":"2016-06-11","ENDY":"182","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-018","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-09-04","STDY":"267","ENDT":"2016-12-06","ENDY":"360","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-018","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-10-29","STDY":"322","ENDT":"2016-10-29","ENDY":"322","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-018","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-13","STDY":"1","ENDT":"2015-12-13","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-018","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-30","STDY":"49","ENDT":"2016-01-30","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-018","SITEID":"01","SITE":"Site 01","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-12-20","STDY":"374","ENDT":"2016-12-20","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-27","STDY":"124","ENDT":"2016-02-25","ENDY":"245","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-08","STDY":"166","ENDT":"2016-02-17","ENDY":"237","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-08","STDY":"228","ENDT":"2016-03-30","ENDY":"279","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-14","STDY":"294","ENDT":"2016-05-26","ENDY":"336","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-16","STDY":"357","ENDT":"2016-06-19","ENDY":"360","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-28","STDY":"33","ENDT":"2015-10-10","ENDY":"107","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-29","STDY":"157","ENDT":"2016-04-07","ENDY":"287","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-08","STDY":"166","ENDT":"2016-01-17","ENDY":"206","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-04","STDY":"224","ENDT":"2016-03-14","ENDY":"263","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-26","STDY":"1","ENDT":"2015-06-26","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-15","STDY":"51","ENDT":"2015-08-15","ENDY":"51","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-019","SITEID":"01","SITE":"Site 01","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-26","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-07-03","STDY":"374","ENDT":"2016-07-03","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-020","SITEID":"01","SITE":"Site 01","AGE":"47","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-01","STDY":"160","ENDT":"2016-01-01","ENDY":"252","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-020","SITEID":"01","SITE":"Site 01","AGE":"47","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-18","STDY":"177","ENDT":"2015-12-13","ENDY":"233","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-020","SITEID":"01","SITE":"Site 01","AGE":"47","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-26","STDY":"246","ENDT":"2015-12-30","ENDY":"250","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-020","SITEID":"01","SITE":"Site 01","AGE":"47","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-15","STDY":"297","ENDT":"2016-03-01","ENDY":"312","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-020","SITEID":"01","SITE":"Site 01","AGE":"47","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-25","STDY":"1","ENDT":"2015-04-25","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-020","SITEID":"01","SITE":"Site 01","AGE":"47","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-15","STDY":"52","ENDT":"2015-06-15","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-020","SITEID":"01","SITE":"Site 01","AGE":"47","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-01","STDY":"373","ENDT":"2016-05-01","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-021","SITEID":"01","SITE":"Site 01","AGE":"23","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-24","STDY":"265","ENDT":"2016-06-26","ENDY":"267","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-021","SITEID":"01","SITE":"Site 01","AGE":"23","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-29","STDY":"26","ENDT":"2016-01-15","ENDY":"104","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-021","SITEID":"01","SITE":"Site 01","AGE":"23","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-31","STDY":"89","ENDT":"2016-08-01","ENDY":"303","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-021","SITEID":"01","SITE":"Site 01","AGE":"23","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-21","STDY":"110","ENDT":"2016-05-23","ENDY":"233","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-021","SITEID":"01","SITE":"Site 01","AGE":"23","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-30","STDY":"119","ENDT":"2016-03-19","ENDY":"168","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-021","SITEID":"01","SITE":"Site 01","AGE":"23","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-04","STDY":"1","ENDT":"2015-10-04","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-021","SITEID":"01","SITE":"Site 01","AGE":"23","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-23","STDY":"51","ENDT":"2015-11-23","ENDY":"51","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-021","SITEID":"01","SITE":"Site 01","AGE":"23","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-09-29","STDY":"362","ENDT":"2016-09-29","ENDY":"362","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-022","SITEID":"01","SITE":"Site 01","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-22","STDY":"114","ENDT":"2016-08-24","ENDY":"329","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-022","SITEID":"01","SITE":"Site 01","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-27","STDY":"240","ENDT":"2016-06-29","ENDY":"273","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-022","SITEID":"01","SITE":"Site 01","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-30","STDY":"274","ENDT":"2016-09-26","ENDY":"362","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-022","SITEID":"01","SITE":"Site 01","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-08-11","STDY":"316","ENDT":"2016-08-28","ENDY":"333","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-022","SITEID":"01","SITE":"Site 01","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-01","STDY":"1","ENDT":"2015-10-01","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-022","SITEID":"01","SITE":"Site 01","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-22","STDY":"53","ENDT":"2015-11-22","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-022","SITEID":"01","SITE":"Site 01","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-04","STDY":"370","ENDT":"2016-10-04","ENDY":"370","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-023","SITEID":"01","SITE":"Site 01","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-23","STDY":"267","ENDT":"2016-08-03","ENDY":"308","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-023","SITEID":"01","SITE":"Site 01","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-01","STDY":"153","ENDT":"2016-08-17","ENDY":"322","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-023","SITEID":"01","SITE":"Site 01","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-11","STDY":"163","ENDT":"2016-09-19","ENDY":"355","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-023","SITEID":"01","SITE":"Site 01","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-03","STDY":"186","ENDT":"2016-04-13","ENDY":"196","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-023","SITEID":"01","SITE":"Site 01","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-03","STDY":"216","ENDT":"2016-09-17","ENDY":"353","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-023","SITEID":"01","SITE":"Site 01","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-01","STDY":"1","ENDT":"2015-10-01","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-023","SITEID":"01","SITE":"Site 01","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-27","STDY":"58","ENDT":"2015-11-27","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-023","SITEID":"01","SITE":"Site 01","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-01","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-01","STDY":"367","ENDT":"2016-10-01","ENDY":"367","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-024","SITEID":"01","SITE":"Site 01","AGE":"48","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-15","STDY":"17","ENDT":"2015-08-06","ENDY":"130","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-024","SITEID":"01","SITE":"Site 01","AGE":"48","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-08","STDY":"163","ENDT":"2016-03-13","ENDY":"350","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-024","SITEID":"01","SITE":"Site 01","AGE":"48","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-09","STDY":"255","ENDT":"2016-01-09","ENDY":"286","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-024","SITEID":"01","SITE":"Site 01","AGE":"48","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-21","STDY":"267","ENDT":"2016-03-23","ENDY":"360","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-024","SITEID":"01","SITE":"Site 01","AGE":"48","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-12","STDY":"289","ENDT":"2016-01-16","ENDY":"293","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-024","SITEID":"01","SITE":"Site 01","AGE":"48","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-03-30","STDY":"1","ENDT":"2015-03-30","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-024","SITEID":"01","SITE":"Site 01","AGE":"48","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-05-17","STDY":"49","ENDT":"2015-05-17","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-024","SITEID":"01","SITE":"Site 01","AGE":"48","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-03-27","STDY":"364","ENDT":"2016-03-27","ENDY":"364","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-025","SITEID":"01","SITE":"Site 01","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-28","STDY":"7","ENDT":"2016-01-29","ENDY":"222","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-025","SITEID":"01","SITE":"Site 01","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-20","STDY":"213","ENDT":"2016-04-17","ENDY":"301","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-025","SITEID":"01","SITE":"Site 01","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-01","STDY":"225","ENDT":"2016-06-07","ENDY":"352","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-025","SITEID":"01","SITE":"Site 01","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-27","STDY":"280","ENDT":"2016-04-22","ENDY":"306","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-025","SITEID":"01","SITE":"Site 01","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-22","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-22","STDY":"1","ENDT":"2015-06-22","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-025","SITEID":"01","SITE":"Site 01","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-22","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-19","STDY":"59","ENDT":"2015-08-19","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-025","SITEID":"01","SITE":"Site 01","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-22","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-28","STDY":"373","ENDT":"2016-06-28","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-04-19","STDY":"60","ENDT":"2015-09-11","ENDY":"205","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-22","STDY":"185","ENDT":"2015-08-23","ENDY":"186","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-13","STDY":"298","ENDT":"2015-12-20","ENDY":"305","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-13","STDY":"360","ENDT":"2016-02-13","ENDY":"360","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-01","STDY":"133","ENDT":"2015-07-03","ENDY":"135","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-28","STDY":"191","ENDT":"2015-09-09","ENDY":"203","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-10","STDY":"357","ENDT":"2016-02-13","ENDY":"360","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-11","STDY":"358","ENDT":"2016-02-11","ENDY":"358","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-02-19","STDY":"1","ENDT":"2015-02-19","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-14","STDY":"55","ENDT":"2015-04-14","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-026","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-02-19","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-13","STDY":"360","ENDT":"2016-02-13","ENDY":"360","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-04-26","STDY":"50","ENDT":"2015-06-06","ENDY":"91","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-22","STDY":"76","ENDT":"2015-07-18","ENDY":"133","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-12","STDY":"97","ENDT":"2015-08-17","ENDY":"163","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-30","STDY":"268","ENDT":"2015-12-26","ENDY":"294","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-01","STDY":"360","ENDT":"2016-03-03","ENDY":"362","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-03-17","STDY":"10","ENDT":"2015-06-15","ENDY":"100","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-03-30","STDY":"23","ENDT":"2015-04-24","ENDY":"48","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-22","STDY":"137","ENDT":"2015-08-13","ENDY":"159","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-17","STDY":"255","ENDT":"2016-02-15","ENDY":"345","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-03-08","STDY":"1","ENDT":"2015-03-08","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-25","STDY":"49","ENDT":"2015-04-25","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-027","SITEID":"01","SITE":"Site 01","AGE":"36","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-08","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-03-10","STDY":"369","ENDT":"2016-03-10","ENDY":"369","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-30","STDY":"30","ENDT":"2016-05-07","ENDY":"342","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-09-06","STDY":"98","ENDT":"2015-12-12","ENDY":"195","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-12","STDY":"226","ENDT":"2016-05-29","ENDY":"364","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-29","STDY":"243","ENDT":"2016-05-07","ENDY":"342","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-01","STDY":"336","ENDT":"2016-05-02","ENDY":"337","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-23","STDY":"53","ENDT":"2015-11-13","ENDY":"166","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-22","STDY":"114","ENDT":"2016-04-24","ENDY":"329","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-01","STDY":"1","ENDT":"2015-06-01","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-25","STDY":"55","ENDT":"2015-07-25","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-028","SITEID":"01","SITE":"Site 01","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-01","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-02","STDY":"368","ENDT":"2016-06-02","ENDY":"368","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-029","SITEID":"01","SITE":"Site 01","AGE":"50","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-06-11","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-15","STDY":"219","ENDT":"2016-03-26","ENDY":"290","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"01-029","SITEID":"01","SITE":"Site 01","AGE":"50","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-06-11","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-11","STDY":"1","ENDT":"2015-06-11","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"01-029","SITEID":"01","SITE":"Site 01","AGE":"50","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-06-11","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-30","STDY":"50","ENDT":"2015-07-30","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"01-029","SITEID":"01","SITE":"Site 01","AGE":"50","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-06-11","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-16","STDY":"372","ENDT":"2016-06-16","ENDY":"372","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"01-030","SITEID":"01","SITE":"Site 01","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-01-18","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-01-18","STDY":"1","ENDT":"2015-01-18","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-001","SITEID":"02","SITE":"Site 02","AGE":"20","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-11","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-12-11","STDY":"1","ENDT":"2015-12-11","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-002","SITEID":"02","SITE":"Site 02","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-09-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-22","STDY":"63","ENDT":"2016-01-13","ENDY":"115","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-002","SITEID":"02","SITE":"Site 02","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-09-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-10","STDY":"294","ENDT":"2016-08-29","ENDY":"344","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-002","SITEID":"02","SITE":"Site 02","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-09-21","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-09-21","STDY":"1","ENDT":"2015-09-21","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-002","SITEID":"02","SITE":"Site 02","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-09-21","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-15","STDY":"56","ENDT":"2015-11-15","ENDY":"56","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-002","SITEID":"02","SITE":"Site 02","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-09-21","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-09-14","STDY":"360","ENDT":"2016-09-14","ENDY":"360","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-18","STDY":"22","ENDT":"2015-08-04","ENDY":"100","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-13","STDY":"201","ENDT":"2016-04-21","ENDY":"361","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-08","STDY":"257","ENDT":"2016-02-25","ENDY":"305","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-12","STDY":"261","ENDT":"2016-02-26","ENDY":"306","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-27","STDY":"307","ENDT":"2016-02-29","ENDY":"309","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-05-09","STDY":"13","ENDT":"2016-04-13","ENDY":"353","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-18","STDY":"267","ENDT":"2016-02-28","ENDY":"308","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-27","STDY":"1","ENDT":"2015-04-27","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-17","STDY":"52","ENDT":"2015-06-17","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-003","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-19","STDY":"359","ENDT":"2016-04-19","ENDY":"359","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-004","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-09-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-20","STDY":"144","ENDT":"2016-07-31","ENDY":"306","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-004","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-09-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-04","STDY":"157","ENDT":"2016-07-07","ENDY":"282","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-004","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-09-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-22","STDY":"267","ENDT":"2016-07-20","ENDY":"295","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-004","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-09-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-22","STDY":"267","ENDT":"2016-09-20","ENDY":"357","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-004","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-09-30","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-09-30","STDY":"1","ENDT":"2015-09-30","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-004","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-09-30","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-26","STDY":"58","ENDT":"2015-11-26","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-004","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-09-30","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-06","STDY":"373","ENDT":"2016-10-06","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-005","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-24","STDY":"287","ENDT":"2016-04-08","ENDY":"331","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-005","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-14","STDY":"1","ENDT":"2015-05-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-005","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-08","STDY":"56","ENDT":"2015-07-08","ENDY":"56","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-005","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-10","STDY":"363","ENDT":"2016-05-10","ENDY":"363","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-006","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-04","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-27","STDY":"24","ENDT":"2016-05-17","ENDY":"349","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-006","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-04","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-11","STDY":"191","ENDT":"2016-01-05","ENDY":"216","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-006","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-04","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-04","STDY":"1","ENDT":"2015-06-04","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-006","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-04","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-01","STDY":"59","ENDT":"2015-08-01","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-006","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-04","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-12","STDY":"375","ENDT":"2016-06-12","ENDY":"375","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-007","SITEID":"02","SITE":"Site 02","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-11-18","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-24","STDY":"7","ENDT":"2016-06-26","ENDY":"222","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-007","SITEID":"02","SITE":"Site 02","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-11-18","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-09","STDY":"174","ENDT":"2016-08-17","ENDY":"274","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-007","SITEID":"02","SITE":"Site 02","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-11-18","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-24","STDY":"189","ENDT":"2016-07-20","ENDY":"246","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-007","SITEID":"02","SITE":"Site 02","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-11-18","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-14","STDY":"210","ENDT":"2016-10-02","ENDY":"320","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-007","SITEID":"02","SITE":"Site 02","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-11-18","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-18","STDY":"1","ENDT":"2015-11-18","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-007","SITEID":"02","SITE":"Site 02","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-11-18","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-18","STDY":"62","ENDT":"2016-01-18","ENDY":"62","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-007","SITEID":"02","SITE":"Site 02","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-11-18","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-24","STDY":"373","ENDT":"2016-11-24","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-008","SITEID":"02","SITE":"Site 02","AGE":"31","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-09-01","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-09-01","STDY":"1","ENDT":"2015-09-01","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-20","STDY":"126","ENDT":"2016-04-26","ENDY":"254","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-07","STDY":"144","ENDT":"2016-07-04","ENDY":"323","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-14","STDY":"151","ENDT":"2016-05-04","ENDY":"262","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-21","STDY":"218","ENDT":"2016-05-26","ENDY":"284","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-20","STDY":"4","ENDT":"2016-02-17","ENDY":"185","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-20","STDY":"35","ENDT":"2015-10-08","ENDY":"53","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-22","STDY":"159","ENDT":"2016-02-28","ENDY":"196","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-18","STDY":"246","ENDT":"2016-08-13","ENDY":"363","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-08-17","STDY":"1","ENDT":"2015-08-17","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-16","STDY":"61","ENDT":"2015-10-16","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-009","SITEID":"02","SITE":"Site 02","AGE":"21","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-08-17","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-08-25","STDY":"375","ENDT":"2016-08-25","ENDY":"375","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-01-22","STDY":"11","ENDT":"2015-08-15","ENDY":"216","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-02-08","STDY":"28","ENDT":"2015-06-04","ENDY":"144","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-07","STDY":"55","ENDT":"2015-04-28","ENDY":"107","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-13","STDY":"153","ENDT":"2015-09-22","ENDY":"254","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-07","STDY":"269","ENDT":"2015-10-23","ENDY":"285","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-01-26","STDY":"15","ENDT":"2016-01-01","ENDY":"355","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-03-20","STDY":"68","ENDT":"2015-08-19","ENDY":"220","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-04","STDY":"174","ENDT":"2015-10-04","ENDY":"266","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-12","STDY":"1","ENDT":"2015-01-12","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-03-04","STDY":"52","ENDT":"2015-03-04","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-010","SITEID":"02","SITE":"Site 02","AGE":"38","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-01-12","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-18","STDY":"372","ENDT":"2016-01-18","ENDY":"372","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-011","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-07-27","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-07-27","STDY":"1","ENDT":"2015-07-27","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-012","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-07-05","STDY":"271","ENDT":"2016-07-26","ENDY":"292","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-012","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-08-05","STDY":"302","ENDT":"2016-08-25","ENDY":"322","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-012","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-09-16","STDY":"344","ENDT":"2016-09-19","ENDY":"347","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-012","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-09","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-25","STDY":"169","ENDT":"2016-05-22","ENDY":"227","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-012","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-09","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-09","STDY":"1","ENDT":"2015-10-09","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-012","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-09","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-07","STDY":"60","ENDT":"2015-12-07","ENDY":"60","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-012","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-10-09","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-11","STDY":"369","ENDT":"2016-10-11","ENDY":"369","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-12","STDY":"4","ENDT":"2015-10-15","ENDY":"221","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-26","STDY":"140","ENDT":"2015-12-13","ENDY":"280","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-19","STDY":"164","ENDT":"2016-01-28","ENDY":"326","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-05","STDY":"272","ENDT":"2016-03-03","ENDY":"361","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-05-19","STDY":"72","ENDT":"2015-11-03","ENDY":"240","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-29","STDY":"174","ENDT":"2016-01-16","ENDY":"314","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-08","STDY":"306","ENDT":"2016-02-03","ENDY":"332","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-20","STDY":"318","ENDT":"2016-02-10","ENDY":"339","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-25","STDY":"354","ENDT":"2016-03-05","ENDY":"363","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-03-09","STDY":"1","ENDT":"2015-03-09","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-05-07","STDY":"60","ENDT":"2015-05-07","ENDY":"60","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-013","SITEID":"02","SITE":"Site 02","AGE":"46","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-28","STDY":"357","ENDT":"2016-02-28","ENDY":"357","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-014","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-13","STDY":"184","ENDT":"2016-03-31","ENDY":"354","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-014","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-16","STDY":"218","ENDT":"2015-11-24","ENDY":"226","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-014","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-24","STDY":"134","ENDT":"2015-10-20","ENDY":"191","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-014","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-06","STDY":"177","ENDT":"2015-12-12","ENDY":"244","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-014","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-30","STDY":"262","ENDT":"2016-03-08","ENDY":"331","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-014","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-11","STDY":"305","ENDT":"2016-02-26","ENDY":"320","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-014","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-13","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-13","STDY":"1","ENDT":"2015-04-13","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-014","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-13","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-06","STDY":"55","ENDT":"2015-06-06","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-014","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-13","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-17","STDY":"371","ENDT":"2016-04-17","ENDY":"371","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-015","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-05","STDY":"8","ENDT":"2015-09-02","ENDY":"128","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-015","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-30","STDY":"186","ENDT":"2015-12-29","ENDY":"246","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-015","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-22","STDY":"239","ENDT":"2016-03-15","ENDY":"323","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-015","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-01","STDY":"280","ENDT":"2016-02-26","ENDY":"305","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-015","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-21","STDY":"329","ENDT":"2016-04-10","ENDY":"349","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-015","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-28","STDY":"1","ENDT":"2015-04-28","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-015","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-23","STDY":"57","ENDT":"2015-06-23","ENDY":"57","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-015","SITEID":"02","SITE":"Site 02","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-25","STDY":"364","ENDT":"2016-04-25","ENDY":"364","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-13","STDY":"18","ENDT":"2015-06-08","ENDY":"105","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-26","STDY":"92","ENDT":"2015-07-24","ENDY":"151","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-11","STDY":"261","ENDT":"2015-11-28","ENDY":"278","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-29","STDY":"279","ENDT":"2016-01-11","ENDY":"322","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-03-27","STDY":"32","ENDT":"2015-12-22","ENDY":"302","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-27","STDY":"63","ENDT":"2015-06-18","ENDY":"115","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-21","STDY":"179","ENDT":"2015-09-28","ENDY":"217","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-07","STDY":"226","ENDT":"2016-02-22","ENDY":"364","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-21","STDY":"240","ENDT":"2016-01-28","ENDY":"339","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-02-24","STDY":"1","ENDT":"2015-02-24","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-18","STDY":"54","ENDT":"2015-04-18","ENDY":"54","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-016","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-24","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-21","STDY":"363","ENDT":"2016-02-21","ENDY":"363","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-26","STDY":"51","ENDT":"2015-09-30","ENDY":"178","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-09","STDY":"65","ENDT":"2016-03-31","ENDY":"361","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-04","STDY":"182","ENDT":"2016-01-21","ENDY":"291","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-19","STDY":"320","ENDT":"2016-03-22","ENDY":"352","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-02","STDY":"332","ENDT":"2016-03-02","ENDY":"332","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-24","STDY":"19","ENDT":"2015-07-22","ENDY":"108","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-05-21","STDY":"46","ENDT":"2015-12-04","ENDY":"243","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-06","STDY":"276","ENDT":"2016-03-09","ENDY":"339","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-05","STDY":"335","ENDT":"2016-03-19","ENDY":"349","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-24","STDY":"354","ENDT":"2016-03-28","ENDY":"358","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-06","STDY":"1","ENDT":"2015-04-06","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-05-25","STDY":"50","ENDT":"2015-05-25","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-017","SITEID":"02","SITE":"Site 02","AGE":"33","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-04-06","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-06","STDY":"367","ENDT":"2016-04-06","ENDY":"367","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-018","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-23","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-06","STDY":"45","ENDT":"2016-11-16","ENDY":"360","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-018","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-23","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-08-03","STDY":"255","ENDT":"2016-10-14","ENDY":"327","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-018","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-23","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-23","STDY":"1","ENDT":"2015-11-23","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-018","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-23","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-12","STDY":"51","ENDT":"2016-01-12","ENDY":"51","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-018","SITEID":"02","SITE":"Site 02","AGE":"19","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-23","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-29","STDY":"373","ENDT":"2016-11-29","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-019","SITEID":"02","SITE":"Site 02","AGE":"49","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-28","STDY":"40","ENDT":"2015-08-18","ENDY":"183","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-019","SITEID":"02","SITE":"Site 02","AGE":"49","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-05","STDY":"78","ENDT":"2015-08-12","ENDY":"177","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-019","SITEID":"02","SITE":"Site 02","AGE":"49","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-23","STDY":"341","ENDT":"2016-02-15","ENDY":"364","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-019","SITEID":"02","SITE":"Site 02","AGE":"49","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-27","STDY":"161","ENDT":"2015-09-07","ENDY":"203","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-019","SITEID":"02","SITE":"Site 02","AGE":"49","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-10","STDY":"267","ENDT":"2016-02-08","ENDY":"357","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-019","SITEID":"02","SITE":"Site 02","AGE":"49","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-31","STDY":"349","ENDT":"2016-02-02","ENDY":"351","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-019","SITEID":"02","SITE":"Site 02","AGE":"49","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-17","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-02-17","STDY":"1","ENDT":"2015-02-17","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-019","SITEID":"02","SITE":"Site 02","AGE":"49","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-17","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-15","STDY":"58","ENDT":"2015-04-15","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-019","SITEID":"02","SITE":"Site 02","AGE":"49","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-17","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-06","STDY":"355","ENDT":"2016-02-06","ENDY":"355","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-020","SITEID":"02","SITE":"Site 02","AGE":"48","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-02","STDY":"21","ENDT":"2015-06-15","ENDY":"65","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-020","SITEID":"02","SITE":"Site 02","AGE":"48","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-19","STDY":"99","ENDT":"2015-08-16","ENDY":"127","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-020","SITEID":"02","SITE":"Site 02","AGE":"48","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-03","STDY":"298","ENDT":"2016-03-21","ENDY":"345","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-020","SITEID":"02","SITE":"Site 02","AGE":"48","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-12","STDY":"307","ENDT":"2016-03-13","ENDY":"337","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-020","SITEID":"02","SITE":"Site 02","AGE":"48","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-01","STDY":"356","ENDT":"2016-04-08","ENDY":"363","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-020","SITEID":"02","SITE":"Site 02","AGE":"48","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-11","STDY":"122","ENDT":"2016-02-11","ENDY":"306","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-020","SITEID":"02","SITE":"Site 02","AGE":"48","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-12","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-12","STDY":"1","ENDT":"2015-04-12","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-020","SITEID":"02","SITE":"Site 02","AGE":"48","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-12","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-08","STDY":"58","ENDT":"2015-06-08","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-020","SITEID":"02","SITE":"Site 02","AGE":"48","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-12","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-01","STDY":"356","ENDT":"2016-04-01","ENDY":"356","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-021","SITEID":"02","SITE":"Site 02","AGE":"23","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-22","STDY":"224","ENDT":"2016-03-01","ENDY":"232","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-021","SITEID":"02","SITE":"Site 02","AGE":"23","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-17","STDY":"248","ENDT":"2016-06-16","ENDY":"339","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-021","SITEID":"02","SITE":"Site 02","AGE":"23","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-01","STDY":"111","ENDT":"2016-05-24","ENDY":"316","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-021","SITEID":"02","SITE":"Site 02","AGE":"23","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-04","STDY":"206","ENDT":"2016-03-09","ENDY":"240","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-021","SITEID":"02","SITE":"Site 02","AGE":"23","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-25","STDY":"227","ENDT":"2016-04-29","ENDY":"291","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-021","SITEID":"02","SITE":"Site 02","AGE":"23","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-07-14","STDY":"1","ENDT":"2015-07-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-021","SITEID":"02","SITE":"Site 02","AGE":"23","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-09-05","STDY":"54","ENDT":"2015-09-05","ENDY":"54","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-021","SITEID":"02","SITE":"Site 02","AGE":"23","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-07-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-07-17","STDY":"370","ENDT":"2016-07-17","ENDY":"370","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-022","SITEID":"02","SITE":"Site 02","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-10","STDY":"70","ENDT":"2016-03-14","ENDY":"165","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-022","SITEID":"02","SITE":"Site 02","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-25","STDY":"207","ENDT":"2016-08-06","ENDY":"310","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-022","SITEID":"02","SITE":"Site 02","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-02","STDY":"1","ENDT":"2015-10-02","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-022","SITEID":"02","SITE":"Site 02","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-23","STDY":"53","ENDT":"2015-11-23","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-022","SITEID":"02","SITE":"Site 02","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-09-27","STDY":"362","ENDT":"2016-09-27","ENDY":"362","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-023","SITEID":"02","SITE":"Site 02","AGE":"20","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-08","STDY":"125","ENDT":"2016-05-18","ENDY":"348","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-023","SITEID":"02","SITE":"Site 02","AGE":"20","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-06","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-06","STDY":"1","ENDT":"2015-06-06","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-023","SITEID":"02","SITE":"Site 02","AGE":"20","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-06","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-27","STDY":"52","ENDT":"2015-07-27","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-023","SITEID":"02","SITE":"Site 02","AGE":"20","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-06-06","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-12","STDY":"373","ENDT":"2016-06-12","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-024","SITEID":"02","SITE":"Site 02","AGE":"45","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-15","STDY":"76","ENDT":"2015-11-02","ENDY":"247","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-024","SITEID":"02","SITE":"Site 02","AGE":"45","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-19","STDY":"141","ENDT":"2016-01-27","ENDY":"333","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-024","SITEID":"02","SITE":"Site 02","AGE":"45","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-29","STDY":"151","ENDT":"2015-12-23","ENDY":"298","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-024","SITEID":"02","SITE":"Site 02","AGE":"45","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-04","STDY":"157","ENDT":"2016-01-04","ENDY":"310","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-024","SITEID":"02","SITE":"Site 02","AGE":"45","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-05","STDY":"158","ENDT":"2016-01-20","ENDY":"326","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-024","SITEID":"02","SITE":"Site 02","AGE":"45","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-13","STDY":"227","ENDT":"2015-10-18","ENDY":"232","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-024","SITEID":"02","SITE":"Site 02","AGE":"45","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-03-01","STDY":"1","ENDT":"2015-03-01","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-024","SITEID":"02","SITE":"Site 02","AGE":"45","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-28","STDY":"59","ENDT":"2015-04-28","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-024","SITEID":"02","SITE":"Site 02","AGE":"45","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-18","STDY":"355","ENDT":"2016-02-18","ENDY":"355","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-025","SITEID":"02","SITE":"Site 02","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-09-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-04","STDY":"39","ENDT":"2016-07-11","ENDY":"289","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-025","SITEID":"02","SITE":"Site 02","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-09-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-26","STDY":"213","ENDT":"2016-08-05","ENDY":"314","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-025","SITEID":"02","SITE":"Site 02","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-09-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-05","STDY":"253","ENDT":"2016-07-29","ENDY":"307","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-025","SITEID":"02","SITE":"Site 02","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-09-27","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-23","STDY":"301","ENDT":"2016-08-07","ENDY":"316","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-025","SITEID":"02","SITE":"Site 02","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-09-27","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-09-27","STDY":"1","ENDT":"2015-09-27","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-025","SITEID":"02","SITE":"Site 02","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-09-27","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-20","STDY":"55","ENDT":"2015-11-20","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-025","SITEID":"02","SITE":"Site 02","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-09-27","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-09-17","STDY":"357","ENDT":"2016-09-17","ENDY":"357","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-026","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-07-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-09","STDY":"242","ENDT":"2016-03-16","ENDY":"249","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-026","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-07-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-19","STDY":"8","ENDT":"2016-05-15","ENDY":"309","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-026","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-07-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-26","STDY":"77","ENDT":"2016-01-03","ENDY":"176","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-026","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-07-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-07","STDY":"180","ENDT":"2016-03-10","ENDY":"243","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-026","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-07-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-01","STDY":"295","ENDT":"2016-06-26","ENDY":"351","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-026","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-07-12","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-07-12","STDY":"1","ENDT":"2015-07-12","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-026","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-07-12","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-30","STDY":"50","ENDT":"2015-08-30","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-026","SITEID":"02","SITE":"Site 02","AGE":"36","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-07-12","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-07-08","STDY":"363","ENDT":"2016-07-08","ENDY":"363","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-027","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-18","STDY":"77","ENDT":"2015-12-20","ENDY":"262","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-027","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-27","STDY":"208","ENDT":"2015-11-22","ENDY":"234","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-027","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-25","STDY":"237","ENDT":"2016-01-14","ENDY":"287","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-027","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-13","STDY":"225","ENDT":"2015-12-10","ENDY":"252","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-027","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-23","STDY":"235","ENDT":"2016-02-09","ENDY":"313","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-027","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-03","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-03","STDY":"1","ENDT":"2015-04-03","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-027","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-03","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-05-24","STDY":"52","ENDT":"2015-05-24","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-027","SITEID":"02","SITE":"Site 02","AGE":"27","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-03","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-01","STDY":"365","ENDT":"2016-04-01","ENDY":"365","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-028","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-04-26","STDY":"2","ENDT":"2015-07-10","ENDY":"77","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-028","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-16","STDY":"206","ENDT":"2016-03-22","ENDY":"333","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-028","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-25","STDY":"1","ENDT":"2015-04-25","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-028","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-16","STDY":"53","ENDT":"2015-06-16","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-028","SITEID":"02","SITE":"Site 02","AGE":"29","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-28","STDY":"370","ENDT":"2016-04-28","ENDY":"370","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-029","SITEID":"02","SITE":"Site 02","AGE":"39","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-13","STDY":"23","ENDT":"2016-01-14","ENDY":"85","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-029","SITEID":"02","SITE":"Site 02","AGE":"39","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-04","STDY":"106","ENDT":"2016-07-01","ENDY":"254","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-029","SITEID":"02","SITE":"Site 02","AGE":"39","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-07-30","STDY":"283","ENDT":"2016-10-02","ENDY":"347","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"02-029","SITEID":"02","SITE":"Site 02","AGE":"39","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-24","STDY":"3","ENDT":"2016-04-16","ENDY":"178","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-029","SITEID":"02","SITE":"Site 02","AGE":"39","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-10","STDY":"172","ENDT":"2016-09-20","ENDY":"335","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"02-029","SITEID":"02","SITE":"Site 02","AGE":"39","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-22","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-22","STDY":"1","ENDT":"2015-10-22","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"02-029","SITEID":"02","SITE":"Site 02","AGE":"39","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-22","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-11","STDY":"51","ENDT":"2015-12-11","ENDY":"51","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"02-029","SITEID":"02","SITE":"Site 02","AGE":"39","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-22","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-11","STDY":"356","ENDT":"2016-10-11","ENDY":"356","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"02-030","SITEID":"02","SITE":"Site 02","AGE":"47","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-27","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-04-27","STDY":"1","ENDT":"2015-04-27","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-21","STDY":"8","ENDT":"2016-09-23","ENDY":"285","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-14","STDY":"92","ENDT":"2016-06-26","ENDY":"196","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-24","STDY":"133","ENDT":"2016-06-30","ENDY":"200","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-08-13","STDY":"244","ENDT":"2016-10-03","ENDY":"295","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-10-08","STDY":"300","ENDT":"2016-10-19","ENDY":"311","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-09-22","STDY":"284","ENDT":"2016-10-10","ENDY":"302","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-11-10","STDY":"333","ENDT":"2016-12-06","ENDY":"359","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-14","STDY":"1","ENDT":"2015-12-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-02-11","STDY":"60","ENDT":"2016-02-11","ENDY":"60","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-001","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-12-04","STDY":"357","ENDT":"2016-12-04","ENDY":"357","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-002","SITEID":"03","SITE":"Site 03","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-11","STDY":"353","ENDT":"2016-04-12","ENDY":"354","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-002","SITEID":"03","SITE":"Site 03","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-25","STDY":"1","ENDT":"2015-04-25","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-002","SITEID":"03","SITE":"Site 03","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-22","STDY":"59","ENDT":"2015-06-22","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-002","SITEID":"03","SITE":"Site 03","AGE":"43","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-23","STDY":"365","ENDT":"2016-04-23","ENDY":"365","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-003","SITEID":"03","SITE":"Site 03","AGE":"27","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-09-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-27","STDY":"87","ENDT":"2016-01-22","ENDY":"143","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-003","SITEID":"03","SITE":"Site 03","AGE":"27","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-09-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-27","STDY":"117","ENDT":"2016-01-08","ENDY":"129","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-003","SITEID":"03","SITE":"Site 03","AGE":"27","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-09-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-29","STDY":"150","ENDT":"2016-03-25","ENDY":"206","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-003","SITEID":"03","SITE":"Site 03","AGE":"27","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-09-02","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-08-31","STDY":"365","ENDT":"2016-08-31","ENDY":"365","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-003","SITEID":"03","SITE":"Site 03","AGE":"27","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-09-02","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-09-02","STDY":"1","ENDT":"2015-09-02","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-003","SITEID":"03","SITE":"Site 03","AGE":"27","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-09-02","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-24","STDY":"53","ENDT":"2015-10-24","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-003","SITEID":"03","SITE":"Site 03","AGE":"27","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-09-02","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-08-24","STDY":"358","ENDT":"2016-08-24","ENDY":"358","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-004","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-05-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-21","STDY":"148","ENDT":"2016-04-29","ENDY":"339","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-004","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-05-27","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-06-28","STDY":"33","ENDT":"2016-04-06","ENDY":"316","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-004","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-05-27","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-17","STDY":"205","ENDT":"2016-02-22","ENDY":"272","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-004","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-05-27","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-11","STDY":"230","ENDT":"2016-05-02","ENDY":"342","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-004","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-05-27","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-27","STDY":"1","ENDT":"2015-05-27","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-004","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-05-27","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-14","STDY":"49","ENDT":"2015-07-14","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-004","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-05-27","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-18","STDY":"358","ENDT":"2016-05-18","ENDY":"358","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-005","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-07-24","STDY":"235","ENDT":"2016-07-26","ENDY":"237","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-005","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-21","STDY":"110","ENDT":"2016-06-17","ENDY":"198","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-005","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-10","STDY":"130","ENDT":"2016-04-18","ENDY":"138","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-005","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-14","STDY":"164","ENDT":"2016-10-23","ENDY":"326","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-005","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-09-11","STDY":"284","ENDT":"2016-10-12","ENDY":"315","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-005","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-09-15","STDY":"288","ENDT":"2016-11-07","ENDY":"341","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-005","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-03","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-03","STDY":"1","ENDT":"2015-12-03","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-005","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-03","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-20","STDY":"49","ENDT":"2016-01-20","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-005","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-03","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-27","STDY":"361","ENDT":"2016-11-27","ENDY":"361","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-006","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-31","STDY":"2","ENDT":"2015-11-14","ENDY":"230","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-006","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-03-30","STDY":"1","ENDT":"2015-03-30","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-006","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-05-23","STDY":"55","ENDT":"2015-05-23","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-006","SITEID":"03","SITE":"Site 03","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-03-30","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-03-20","STDY":"357","ENDT":"2016-03-20","ENDY":"357","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-007","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-03-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-28","STDY":"73","ENDT":"2015-07-03","ENDY":"109","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-007","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-03-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-12","STDY":"271","ENDT":"2016-03-14","ENDY":"364","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-007","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-03-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-26","STDY":"194","ENDT":"2016-03-15","ENDY":"365","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-007","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-03-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-19","STDY":"278","ENDT":"2016-02-28","ENDY":"349","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-007","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-03-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-09","STDY":"359","ENDT":"2016-03-11","ENDY":"361","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-007","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-03-17","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-03-17","STDY":"1","ENDT":"2015-03-17","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-007","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-03-17","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-05-08","STDY":"53","ENDT":"2015-05-08","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-007","SITEID":"03","SITE":"Site 03","AGE":"42","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-03-17","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-03-10","STDY":"360","ENDT":"2016-03-10","ENDY":"360","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-008","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-03","STDY":"46","ENDT":"2015-10-24","ENDY":"67","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-008","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-06","STDY":"49","ENDT":"2015-11-15","ENDY":"89","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-008","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-02","STDY":"76","ENDT":"2016-07-24","ENDY":"341","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-008","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-22","STDY":"217","ENDT":"2016-05-19","ENDY":"275","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-008","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-30","STDY":"256","ENDT":"2016-07-11","ENDY":"328","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-008","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-08-19","STDY":"1","ENDT":"2015-08-19","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-008","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-19","STDY":"62","ENDT":"2015-10-19","ENDY":"62","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-008","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-08-19","STDY":"367","ENDT":"2016-08-19","ENDY":"367","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-009","SITEID":"03","SITE":"Site 03","AGE":"27","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-06-17","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-06-17","STDY":"1","ENDT":"2015-06-17","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-010","SITEID":"03","SITE":"Site 03","AGE":"28","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-15","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-02","STDY":"80","ENDT":"2016-03-18","ENDY":"125","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-010","SITEID":"03","SITE":"Site 03","AGE":"28","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-15","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-08","STDY":"146","ENDT":"2016-05-10","ENDY":"178","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-010","SITEID":"03","SITE":"Site 03","AGE":"28","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-15","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-07","STDY":"206","ENDT":"2016-10-31","ENDY":"352","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-010","SITEID":"03","SITE":"Site 03","AGE":"28","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-15","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-08-23","STDY":"283","ENDT":"2016-09-19","ENDY":"310","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-010","SITEID":"03","SITE":"Site 03","AGE":"28","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-15","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-11","STDY":"58","ENDT":"2016-08-06","ENDY":"266","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-010","SITEID":"03","SITE":"Site 03","AGE":"28","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-15","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-10-11","STDY":"332","ENDT":"2016-11-09","ENDY":"361","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-010","SITEID":"03","SITE":"Site 03","AGE":"28","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-15","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-15","STDY":"1","ENDT":"2015-11-15","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-010","SITEID":"03","SITE":"Site 03","AGE":"28","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-15","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-04","STDY":"51","ENDT":"2016-01-04","ENDY":"51","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-010","SITEID":"03","SITE":"Site 03","AGE":"28","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-11-15","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-08","STDY":"360","ENDT":"2016-11-08","ENDY":"360","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-02-26","STDY":"22","ENDT":"2015-10-27","ENDY":"265","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-28","STDY":"174","ENDT":"2015-08-23","ENDY":"200","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-19","STDY":"288","ENDT":"2016-01-03","ENDY":"333","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-20","STDY":"350","ENDT":"2016-01-28","ENDY":"358","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-21","STDY":"76","ENDT":"2015-06-14","ENDY":"130","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-01","STDY":"239","ENDT":"2015-12-24","ENDY":"323","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-12","STDY":"281","ENDT":"2016-01-26","ENDY":"356","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-02-05","STDY":"1","ENDT":"2015-02-05","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-05","STDY":"60","ENDT":"2015-04-05","ENDY":"60","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-011","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-02-05","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-08","STDY":"369","ENDT":"2016-02-08","ENDY":"369","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-012","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-23","STDY":"66","ENDT":"2015-11-27","ENDY":"101","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-012","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-29","STDY":"133","ENDT":"2016-03-19","ENDY":"214","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-012","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-07-12","STDY":"329","ENDT":"2016-07-30","ENDY":"347","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-012","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-31","STDY":"74","ENDT":"2016-02-10","ENDY":"176","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-012","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-22","STDY":"217","ENDT":"2016-07-18","ENDY":"335","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-012","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-04","STDY":"321","ENDT":"2016-08-10","ENDY":"358","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-012","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-08-19","STDY":"1","ENDT":"2015-08-19","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-012","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-10","STDY":"53","ENDT":"2015-10-10","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-012","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-19","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-08-22","STDY":"370","ENDT":"2016-08-22","ENDY":"370","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-013","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-10-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-06","STDY":"10","ENDT":"2016-06-03","ENDY":"220","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-013","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-10-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-11","STDY":"45","ENDT":"2016-08-24","ENDY":"302","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-013","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-10-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-03","STDY":"128","ENDT":"2016-05-08","ENDY":"194","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-013","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-10-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-14","STDY":"200","ENDT":"2016-06-02","ENDY":"219","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-013","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-10-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-10-26","STDY":"365","ENDT":"2016-10-26","ENDY":"365","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-013","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-10-28","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-10-05","STDY":"344","ENDT":"2016-10-22","ENDY":"361","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-013","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-10-28","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-28","STDY":"1","ENDT":"2015-10-28","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-013","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-10-28","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-27","STDY":"61","ENDT":"2015-12-27","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-013","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-10-28","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-04","STDY":"374","ENDT":"2016-11-04","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-014","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-05","STDY":"27","ENDT":"2015-12-09","ENDY":"306","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-014","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-04-01","STDY":"54","ENDT":"2015-04-06","ENDY":"59","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-014","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-12","STDY":"95","ENDT":"2016-01-13","ENDY":"341","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-014","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-30","STDY":"174","ENDT":"2015-08-03","ENDY":"178","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-014","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-04","STDY":"240","ENDT":"2015-10-07","ENDY":"243","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-014","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-04","STDY":"57","ENDT":"2015-10-30","ENDY":"266","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-014","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-02-07","STDY":"1","ENDT":"2015-02-07","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-014","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-08","STDY":"61","ENDT":"2015-04-08","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-014","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-15","STDY":"374","ENDT":"2016-02-15","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-015","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-30","STDY":"4","ENDT":"2015-07-09","ENDY":"13","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-015","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-16","STDY":"143","ENDT":"2016-05-13","ENDY":"322","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-015","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-17","STDY":"326","ENDT":"2016-05-28","ENDY":"337","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-015","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-27","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-29","STDY":"95","ENDT":"2016-02-19","ENDY":"238","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-015","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-27","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-27","STDY":"1","ENDT":"2015-06-27","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-015","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-27","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-16","STDY":"51","ENDT":"2015-08-16","ENDY":"51","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-015","SITEID":"03","SITE":"Site 03","AGE":"33","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-06-27","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-19","STDY":"359","ENDT":"2016-06-19","ENDY":"359","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-016","SITEID":"03","SITE":"Site 03","AGE":"24","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-07-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-09","STDY":"173","ENDT":"2016-05-23","ENDY":"308","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-016","SITEID":"03","SITE":"Site 03","AGE":"24","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-07-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-08","STDY":"263","ENDT":"2016-06-05","ENDY":"321","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-016","SITEID":"03","SITE":"Site 03","AGE":"24","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-07-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-25","STDY":"341","ENDT":"2016-07-19","ENDY":"365","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-016","SITEID":"03","SITE":"Site 03","AGE":"24","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-07-21","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-07-21","STDY":"1","ENDT":"2015-07-21","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-016","SITEID":"03","SITE":"Site 03","AGE":"24","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-07-21","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-09-13","STDY":"55","ENDT":"2015-09-13","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-016","SITEID":"03","SITE":"Site 03","AGE":"24","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-07-21","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-07-19","STDY":"365","ENDT":"2016-07-19","ENDY":"365","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-09-11","STDY":"131","ENDT":"2015-10-25","ENDY":"175","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-12","STDY":"314","ENDT":"2016-03-15","ENDY":"317","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-06-30","STDY":"58","ENDT":"2015-07-31","ENDY":"89","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-12","STDY":"101","ENDT":"2015-09-27","ENDY":"147","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-07","STDY":"188","ENDT":"2016-03-19","ENDY":"321","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-12","STDY":"254","ENDT":"2016-04-29","ENDY":"362","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-18","STDY":"320","ENDT":"2016-04-19","ENDY":"352","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-04","STDY":"1","ENDT":"2015-05-04","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-21","STDY":"49","ENDT":"2015-06-21","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-017","SITEID":"03","SITE":"Site 03","AGE":"20","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-05-04","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-26","STDY":"359","ENDT":"2016-04-26","ENDY":"359","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-018","SITEID":"03","SITE":"Site 03","AGE":"26","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-14","STDY":"78","ENDT":"2015-10-21","ENDY":"177","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-018","SITEID":"03","SITE":"Site 03","AGE":"26","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-10","STDY":"105","ENDT":"2016-01-09","ENDY":"257","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-018","SITEID":"03","SITE":"Site 03","AGE":"26","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-08","STDY":"134","ENDT":"2016-02-22","ENDY":"301","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-018","SITEID":"03","SITE":"Site 03","AGE":"26","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-28","STDY":"1","ENDT":"2015-04-28","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-018","SITEID":"03","SITE":"Site 03","AGE":"26","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-17","STDY":"51","ENDT":"2015-06-17","ENDY":"51","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-018","SITEID":"03","SITE":"Site 03","AGE":"26","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-28","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-01","STDY":"370","ENDT":"2016-05-01","ENDY":"370","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-09","STDY":"225","ENDT":"2016-03-29","ENDY":"305","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-26","STDY":"302","ENDT":"2016-04-08","ENDY":"315","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-18","STDY":"81","ENDT":"2015-09-02","ENDY":"96","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-25","STDY":"149","ENDT":"2016-04-25","ENDY":"332","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-05","STDY":"190","ENDT":"2016-05-14","ENDY":"351","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-16","STDY":"201","ENDT":"2016-03-31","ENDY":"307","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-04","STDY":"311","ENDT":"2016-05-07","ENDY":"344","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-30","STDY":"1","ENDT":"2015-05-30","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-27","STDY":"59","ENDT":"2015-07-27","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-019","SITEID":"03","SITE":"Site 03","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-30","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-27","STDY":"364","ENDT":"2016-05-27","ENDY":"364","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-020","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-07-02","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-26","STDY":"87","ENDT":"2016-01-21","ENDY":"204","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-020","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-07-02","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-05","STDY":"127","ENDT":"2016-04-27","ENDY":"301","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-020","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-07-02","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-15","STDY":"137","ENDT":"2016-01-21","ENDY":"204","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-020","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-07-02","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-18","STDY":"322","ENDT":"2016-05-22","ENDY":"326","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-020","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-07-02","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-07-02","STDY":"1","ENDT":"2015-07-02","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-020","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-07-02","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-20","STDY":"50","ENDT":"2015-08-20","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-020","SITEID":"03","SITE":"Site 03","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-07-02","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-28","STDY":"363","ENDT":"2016-06-28","ENDY":"363","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-021","SITEID":"03","SITE":"Site 03","AGE":"51","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-26","STDY":"45","ENDT":"2016-06-30","ENDY":"232","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-021","SITEID":"03","SITE":"Site 03","AGE":"51","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-09","STDY":"150","ENDT":"2016-09-16","ENDY":"310","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-021","SITEID":"03","SITE":"Site 03","AGE":"51","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-03","STDY":"22","ENDT":"2016-02-20","ENDY":"101","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-021","SITEID":"03","SITE":"Site 03","AGE":"51","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-09","STDY":"119","ENDT":"2016-11-01","ENDY":"356","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-021","SITEID":"03","SITE":"Site 03","AGE":"51","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-31","STDY":"263","ENDT":"2016-09-27","ENDY":"321","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-021","SITEID":"03","SITE":"Site 03","AGE":"51","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-09-09","STDY":"303","ENDT":"2016-10-03","ENDY":"327","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-021","SITEID":"03","SITE":"Site 03","AGE":"51","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-12","STDY":"1","ENDT":"2015-11-12","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-021","SITEID":"03","SITE":"Site 03","AGE":"51","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-06","STDY":"56","ENDT":"2016-01-06","ENDY":"56","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-021","SITEID":"03","SITE":"Site 03","AGE":"51","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-15","STDY":"370","ENDT":"2016-11-15","ENDY":"370","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-022","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-04","STDY":"144","ENDT":"2015-10-22","ENDY":"162","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-022","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-21","STDY":"161","ENDT":"2015-11-19","ENDY":"190","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-022","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-04","STDY":"114","ENDT":"2015-10-31","ENDY":"171","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-022","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-19","STDY":"251","ENDT":"2016-03-08","ENDY":"300","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-022","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-14","STDY":"1","ENDT":"2015-05-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-022","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-07","STDY":"55","ENDT":"2015-07-07","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-022","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-06","STDY":"359","ENDT":"2016-05-06","ENDY":"359","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-023","SITEID":"03","SITE":"Site 03","AGE":"46","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-18","STDY":"210","ENDT":"2015-08-18","ENDY":"210","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-023","SITEID":"03","SITE":"Site 03","AGE":"46","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-03","STDY":"226","ENDT":"2015-10-24","ENDY":"277","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-023","SITEID":"03","SITE":"Site 03","AGE":"46","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-21","STDY":"1","ENDT":"2015-01-21","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-023","SITEID":"03","SITE":"Site 03","AGE":"46","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-03-24","STDY":"63","ENDT":"2015-03-24","ENDY":"63","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-023","SITEID":"03","SITE":"Site 03","AGE":"46","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-10","STDY":"355","ENDT":"2016-01-10","ENDY":"355","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-024","SITEID":"03","SITE":"Site 03","AGE":"52","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-03-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-29","STDY":"249","ENDT":"2015-12-06","ENDY":"256","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-024","SITEID":"03","SITE":"Site 03","AGE":"52","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-03-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-24","STDY":"336","ENDT":"2016-03-01","ENDY":"342","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-024","SITEID":"03","SITE":"Site 03","AGE":"52","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-03-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-09","STDY":"198","ENDT":"2016-03-23","ENDY":"364","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-024","SITEID":"03","SITE":"Site 03","AGE":"52","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-03-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-19","STDY":"269","ENDT":"2016-02-19","ENDY":"331","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-024","SITEID":"03","SITE":"Site 03","AGE":"52","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-03-26","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-03-26","STDY":"1","ENDT":"2015-03-26","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-024","SITEID":"03","SITE":"Site 03","AGE":"52","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-03-26","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-05-23","STDY":"59","ENDT":"2015-05-23","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-024","SITEID":"03","SITE":"Site 03","AGE":"52","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-03-26","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-02","STDY":"374","ENDT":"2016-04-02","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-025","SITEID":"03","SITE":"Site 03","AGE":"27","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-03-17","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-03-17","STDY":"1","ENDT":"2015-03-17","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-026","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-04-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-29","STDY":"244","ENDT":"2016-03-03","ENDY":"309","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-026","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-04-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-04","STDY":"250","ENDT":"2016-04-11","ENDY":"348","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-026","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-04-30","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-30","STDY":"1","ENDT":"2015-04-30","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-026","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-04-30","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-26","STDY":"58","ENDT":"2015-06-26","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-026","SITEID":"03","SITE":"Site 03","AGE":"53","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-04-30","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-18","STDY":"355","ENDT":"2016-04-18","ENDY":"355","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-09-14","STDY":"125","ENDT":"2016-01-12","ENDY":"245","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-09-24","STDY":"135","ENDT":"2015-10-10","ENDY":"151","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-23","STDY":"316","ENDT":"2016-04-20","ENDY":"344","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-06-20","STDY":"39","ENDT":"2016-02-25","ENDY":"289","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-18","STDY":"98","ENDT":"2015-11-28","ENDY":"200","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-05","STDY":"177","ENDT":"2016-04-07","ENDY":"331","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-03","STDY":"296","ENDT":"2016-03-05","ENDY":"298","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-13","STDY":"1","ENDT":"2015-05-13","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-01","STDY":"50","ENDT":"2015-07-01","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-027","SITEID":"03","SITE":"Site 03","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-13","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-07","STDY":"361","ENDT":"2016-05-07","ENDY":"361","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-028","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-11","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-12","STDY":"247","ENDT":"2016-01-15","ENDY":"250","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-028","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-11","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-20","STDY":"346","ENDT":"2016-04-22","ENDY":"348","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-028","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-11","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-11","STDY":"1","ENDT":"2015-05-11","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-028","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-11","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-01","STDY":"52","ENDT":"2015-07-01","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-028","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-11","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-17","STDY":"373","ENDT":"2016-05-17","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-029","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-05","STDY":"58","ENDT":"2015-07-17","ENDY":"131","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-029","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-22","STDY":"75","ENDT":"2015-11-23","ENDY":"260","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-029","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-09-05","STDY":"181","ENDT":"2016-03-06","ENDY":"364","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"03-029","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-05","STDY":"242","ENDT":"2015-11-12","ENDY":"249","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"03-029","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-03-09","STDY":"1","ENDT":"2015-03-09","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"03-029","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-05-08","STDY":"61","ENDT":"2015-05-08","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"03-029","SITEID":"03","SITE":"Site 03","AGE":"37","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-03-09","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-26","STDY":"355","ENDT":"2016-02-26","ENDY":"355","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"03-030","SITEID":"03","SITE":"Site 03","AGE":"25","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-10-24","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-10-24","STDY":"1","ENDT":"2015-10-24","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-001","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-10-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-15","STDY":"35","ENDT":"2016-03-31","ENDY":"172","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-001","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-10-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-25","STDY":"197","ENDT":"2016-04-25","ENDY":"197","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-001","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-10-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-08-20","STDY":"314","ENDT":"2016-09-19","ENDY":"344","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-001","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-10-12","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-12","STDY":"1","ENDT":"2015-10-12","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-001","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-10-12","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-30","STDY":"50","ENDT":"2015-11-30","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-001","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-10-12","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-03","STDY":"358","ENDT":"2016-10-03","ENDY":"358","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-002","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-02-11","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-02-11","STDY":"1","ENDT":"2015-02-11","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-14","STDY":"178","ENDT":"2016-02-10","ENDY":"236","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-21","STDY":"185","ENDT":"2016-01-08","ENDY":"203","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-01","STDY":"317","ENDT":"2016-05-29","ENDY":"345","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-08","STDY":"81","ENDT":"2015-10-31","ENDY":"134","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-10","STDY":"144","ENDT":"2015-12-24","ENDY":"188","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-01","STDY":"227","ENDT":"2016-04-20","ENDY":"306","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-03","STDY":"258","ENDT":"2016-05-04","ENDY":"320","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-03","STDY":"289","ENDT":"2016-04-03","ENDY":"289","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-20","STDY":"1","ENDT":"2015-06-20","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-11","STDY":"53","ENDT":"2015-08-11","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-003","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-10","STDY":"357","ENDT":"2016-06-10","ENDY":"357","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-03","STDY":"17","ENDT":"2016-07-03","ENDY":"230","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-02","STDY":"47","ENDT":"2016-09-29","ENDY":"318","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-03","STDY":"48","ENDT":"2016-01-11","ENDY":"56","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-01","STDY":"106","ENDT":"2016-10-09","ENDY":"328","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-17","STDY":"153","ENDT":"2016-07-01","ENDY":"228","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-11","STDY":"25","ENDT":"2016-10-26","ENDY":"345","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-12","STDY":"209","ENDT":"2016-10-11","ENDY":"330","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-12","STDY":"239","ENDT":"2016-07-20","ENDY":"247","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-15","STDY":"242","ENDT":"2016-07-22","ENDY":"249","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-17","STDY":"1","ENDT":"2015-11-17","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-05","STDY":"50","ENDT":"2016-01-05","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-004","SITEID":"04","SITE":"Site 04","AGE":"25","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-11-17","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-21","STDY":"371","ENDT":"2016-11-21","ENDY":"371","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-005","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-16","STDY":"167","ENDT":"2016-01-17","ENDY":"168","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-005","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-22","STDY":"173","ENDT":"2016-03-24","ENDY":"235","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-005","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-31","STDY":"182","ENDT":"2016-02-05","ENDY":"187","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-005","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-20","STDY":"202","ENDT":"2016-07-21","ENDY":"354","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-005","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-26","STDY":"208","ENDT":"2016-03-24","ENDY":"235","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-005","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-11","STDY":"283","ENDT":"2016-05-18","ENDY":"290","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-005","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-03","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-08-03","STDY":"1","ENDT":"2015-08-03","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-005","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-03","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-03","STDY":"62","ENDT":"2015-10-03","ENDY":"62","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-005","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-08-03","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-07-24","STDY":"357","ENDT":"2016-07-24","ENDY":"357","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-006","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-08-18","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-24","STDY":"7","ENDT":"2016-02-25","ENDY":"192","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-006","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-08-18","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-05","STDY":"141","ENDT":"2016-03-09","ENDY":"205","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-006","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-08-18","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-05","STDY":"201","ENDT":"2016-06-12","ENDY":"300","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-006","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-08-18","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-15","STDY":"211","ENDT":"2016-04-04","ENDY":"231","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-006","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-08-18","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-15","STDY":"242","ENDT":"2016-05-27","ENDY":"284","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-006","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-08-18","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-08-18","STDY":"1","ENDT":"2015-08-18","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-006","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-08-18","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-08","STDY":"52","ENDT":"2015-10-08","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-006","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-08-18","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-08-13","STDY":"362","ENDT":"2016-08-13","ENDY":"362","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-007","SITEID":"04","SITE":"Site 04","AGE":"23","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-11-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-15","STDY":"2","ENDT":"2015-12-09","ENDY":"26","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-007","SITEID":"04","SITE":"Site 04","AGE":"23","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-11-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-06","STDY":"145","ENDT":"2016-06-05","ENDY":"205","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-007","SITEID":"04","SITE":"Site 04","AGE":"23","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-11-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-10-19","STDY":"341","ENDT":"2016-11-01","ENDY":"354","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-007","SITEID":"04","SITE":"Site 04","AGE":"23","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-11-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-11","STDY":"180","ENDT":"2016-05-18","ENDY":"187","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-007","SITEID":"04","SITE":"Site 04","AGE":"23","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-11-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-09-02","STDY":"294","ENDT":"2016-09-28","ENDY":"320","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-007","SITEID":"04","SITE":"Site 04","AGE":"23","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-11-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-14","STDY":"1","ENDT":"2015-11-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-007","SITEID":"04","SITE":"Site 04","AGE":"23","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-11-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-09","STDY":"57","ENDT":"2016-01-09","ENDY":"57","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-007","SITEID":"04","SITE":"Site 04","AGE":"23","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-11-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-20","STDY":"373","ENDT":"2016-11-20","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-008","SITEID":"04","SITE":"Site 04","AGE":"43","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-07-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-13","STDY":"221","ENDT":"2016-07-05","ENDY":"364","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-008","SITEID":"04","SITE":"Site 04","AGE":"43","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-07-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-22","STDY":"230","ENDT":"2016-02-27","ENDY":"235","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-008","SITEID":"04","SITE":"Site 04","AGE":"43","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-07-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-14","STDY":"312","ENDT":"2016-06-20","ENDY":"349","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-008","SITEID":"04","SITE":"Site 04","AGE":"43","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-07-08","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-24","STDY":"232","ENDT":"2016-02-26","ENDY":"234","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-008","SITEID":"04","SITE":"Site 04","AGE":"43","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-07-08","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-30","STDY":"267","ENDT":"2016-04-11","ENDY":"279","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-008","SITEID":"04","SITE":"Site 04","AGE":"43","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-07-08","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-07-08","STDY":"1","ENDT":"2015-07-08","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-008","SITEID":"04","SITE":"Site 04","AGE":"43","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-07-08","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-09-01","STDY":"56","ENDT":"2015-09-01","ENDY":"56","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-008","SITEID":"04","SITE":"Site 04","AGE":"43","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-07-08","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-07-16","STDY":"375","ENDT":"2016-07-16","ENDY":"375","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-04-18","STDY":"9","ENDT":"2016-02-18","ENDY":"315","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-04-26","STDY":"17","ENDT":"2015-10-07","ENDY":"181","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-06","STDY":"27","ENDT":"2015-09-14","ENDY":"158","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-21","STDY":"103","ENDT":"2015-11-10","ENDY":"215","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-20","STDY":"346","ENDT":"2016-03-27","ENDY":"353","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-09","STDY":"91","ENDT":"2016-02-15","ENDY":"312","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-27","STDY":"353","ENDT":"2016-03-28","ENDY":"354","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-10","STDY":"1","ENDT":"2015-04-10","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-06","STDY":"58","ENDT":"2015-06-06","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-009","SITEID":"04","SITE":"Site 04","AGE":"31","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-04-10","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-10","STDY":"367","ENDT":"2016-04-10","ENDY":"367","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-010","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-21","STDY":"90","ENDT":"2015-09-10","ENDY":"232","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-010","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-27","STDY":"96","ENDT":"2015-09-30","ENDY":"252","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-010","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-20","STDY":"211","ENDT":"2015-11-09","ENDY":"292","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-010","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-22","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-22","STDY":"1","ENDT":"2015-01-22","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-010","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-22","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-03-18","STDY":"56","ENDT":"2015-03-18","ENDY":"56","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-010","SITEID":"04","SITE":"Site 04","AGE":"39","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-01-22","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-21","STDY":"365","ENDT":"2016-01-21","ENDY":"365","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-21","STDY":"26","ENDT":"2016-07-03","ENDY":"221","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-22","STDY":"27","ENDT":"2016-07-13","ENDY":"231","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-01","STDY":"37","ENDT":"2016-06-10","ENDY":"198","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-09-05","STDY":"285","ENDT":"2016-11-10","ENDY":"351","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-13","STDY":"49","ENDT":"2016-03-09","ENDY":"105","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-16","STDY":"143","ENDT":"2016-07-15","ENDY":"233","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-09","STDY":"166","ENDT":"2016-10-17","ENDY":"327","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-26","STDY":"1","ENDT":"2015-11-26","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-23","STDY":"59","ENDT":"2016-01-23","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-011","SITEID":"04","SITE":"Site 04","AGE":"44","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-30","STDY":"371","ENDT":"2016-11-30","ENDY":"371","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-012","SITEID":"04","SITE":"Site 04","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-08-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-17","STDY":"2","ENDT":"2016-04-01","ENDY":"230","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-012","SITEID":"04","SITE":"Site 04","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-08-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-23","STDY":"313","ENDT":"2016-07-30","ENDY":"350","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-012","SITEID":"04","SITE":"Site 04","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-08-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-25","STDY":"345","ENDT":"2016-07-30","ENDY":"350","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-012","SITEID":"04","SITE":"Site 04","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-08-16","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-08-16","STDY":"1","ENDT":"2015-08-16","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-012","SITEID":"04","SITE":"Site 04","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-08-16","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-15","STDY":"61","ENDT":"2015-10-15","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-012","SITEID":"04","SITE":"Site 04","AGE":"49","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-08-16","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-08-06","STDY":"357","ENDT":"2016-08-06","ENDY":"357","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-013","SITEID":"04","SITE":"Site 04","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-10-16","STDY":"346","ENDT":"2016-10-24","ENDY":"354","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-013","SITEID":"04","SITE":"Site 04","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-06","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-06","STDY":"1","ENDT":"2015-11-06","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-013","SITEID":"04","SITE":"Site 04","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-06","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-26","STDY":"51","ENDT":"2015-12-26","ENDY":"51","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-013","SITEID":"04","SITE":"Site 04","AGE":"18","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-06","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-26","STDY":"356","ENDT":"2016-10-26","ENDY":"356","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-14","STDY":"23","ENDT":"2015-12-16","ENDY":"239","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-09","STDY":"232","ENDT":"2016-02-12","ENDY":"297","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-01","STDY":"255","ENDT":"2016-02-13","ENDY":"298","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-01","STDY":"286","ENDT":"2016-02-06","ENDY":"291","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-06","STDY":"320","ENDT":"2016-04-14","ENDY":"359","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-06","STDY":"76","ENDT":"2016-03-27","ENDY":"341","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-30","STDY":"162","ENDT":"2015-10-04","ENDY":"166","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-09","STDY":"202","ENDT":"2016-03-23","ENDY":"337","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-03","STDY":"226","ENDT":"2016-03-15","ENDY":"329","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-22","STDY":"1","ENDT":"2015-04-22","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-18","STDY":"58","ENDT":"2015-06-18","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-014","SITEID":"04","SITE":"Site 04","AGE":"19","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-04-22","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-10","STDY":"355","ENDT":"2016-04-10","ENDY":"355","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-015","SITEID":"04","SITE":"Site 04","AGE":"52","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-12","STDY":"49","ENDT":"2015-08-21","ENDY":"89","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-015","SITEID":"04","SITE":"Site 04","AGE":"52","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-14","STDY":"266","ENDT":"2016-04-21","ENDY":"333","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-015","SITEID":"04","SITE":"Site 04","AGE":"52","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-07","STDY":"319","ENDT":"2016-04-23","ENDY":"335","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-015","SITEID":"04","SITE":"Site 04","AGE":"52","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-25","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-25","STDY":"1","ENDT":"2015-05-25","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-015","SITEID":"04","SITE":"Site 04","AGE":"52","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-25","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-13","STDY":"50","ENDT":"2015-07-13","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-015","SITEID":"04","SITE":"Site 04","AGE":"52","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-05-25","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-21","STDY":"363","ENDT":"2016-05-21","ENDY":"363","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-016","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-05","STDY":"206","ENDT":"2016-11-28","ENDY":"352","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-016","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-08-18","STDY":"250","ENDT":"2016-09-10","ENDY":"273","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-016","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-08-21","STDY":"253","ENDT":"2016-09-28","ENDY":"291","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-016","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-09-16","STDY":"279","ENDT":"2016-09-16","ENDY":"279","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-016","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-13","STDY":"1","ENDT":"2015-12-13","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-016","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-02-07","STDY":"57","ENDT":"2016-02-07","ENDY":"57","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-016","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-12-13","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-12-05","STDY":"359","ENDT":"2016-12-05","ENDY":"359","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-017","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-20","STDY":"85","ENDT":"2015-12-14","ENDY":"201","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-017","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-13","STDY":"139","ENDT":"2016-03-30","ENDY":"308","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-017","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-03","STDY":"252","ENDT":"2016-05-11","ENDY":"350","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-017","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-28","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-16","STDY":"294","ENDT":"2016-04-28","ENDY":"337","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-017","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-28","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-28","STDY":"1","ENDT":"2015-05-28","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-017","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-28","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-26","STDY":"60","ENDT":"2015-07-26","ENDY":"60","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-017","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"F","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-05-28","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-24","STDY":"363","ENDT":"2016-05-24","ENDY":"363","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-018","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-27","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-01-27","STDY":"1","ENDT":"2015-01-27","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-019","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-06-13","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-06-13","STDY":"1","ENDT":"2015-06-13","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-02-19","STDY":"30","ENDT":"2015-03-26","ENDY":"65","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-05","STDY":"44","ENDT":"2015-11-08","ENDY":"292","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-13","STDY":"52","ENDT":"2015-11-29","ENDY":"313","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-04","STDY":"165","ENDT":"2015-12-24","ENDY":"338","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-01","STDY":"193","ENDT":"2015-10-19","ENDY":"272","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-03-20","STDY":"59","ENDT":"2015-11-23","ENDY":"307","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-06-25","STDY":"156","ENDT":"2015-12-16","ENDY":"330","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-16","STDY":"208","ENDT":"2015-10-30","ENDY":"283","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-21","STDY":"1","ENDT":"2015-01-21","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-03-22","STDY":"61","ENDT":"2015-03-22","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-020","SITEID":"04","SITE":"Site 04","AGE":"55","SEX":"F","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-01-21","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-22","STDY":"367","ENDT":"2016-01-22","ENDY":"367","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-27","STDY":"44","ENDT":"2015-11-13","ENDY":"61","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-05","STDY":"53","ENDT":"2016-01-29","ENDY":"138","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-01","STDY":"79","ENDT":"2016-07-20","ENDY":"311","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-12","STDY":"90","ENDT":"2016-06-03","ENDY":"264","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-14","STDY":"244","ENDT":"2016-07-19","ENDY":"310","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-16","STDY":"277","ENDT":"2016-07-08","ENDY":"299","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-22","STDY":"283","ENDT":"2016-06-25","ENDY":"286","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-08-28","STDY":"350","ENDT":"2016-09-05","ENDY":"358","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-09-14","STDY":"1","ENDT":"2015-09-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-06","STDY":"54","ENDT":"2015-11-06","ENDY":"54","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-021","SITEID":"04","SITE":"Site 04","AGE":"24","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-09-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-09-14","STDY":"367","ENDT":"2016-09-14","ENDY":"367","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-022","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-24","STDY":"35","ENDT":"2015-12-09","ENDY":"173","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-022","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-05","STDY":"47","ENDT":"2016-06-01","ENDY":"348","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-022","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-18","STDY":"152","ENDT":"2015-12-25","ENDY":"189","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-022","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-28","STDY":"192","ENDT":"2016-05-21","ENDY":"337","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-022","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-27","STDY":"253","ENDT":"2016-04-10","ENDY":"296","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-022","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-20","STDY":"1","ENDT":"2015-06-20","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-022","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-12","STDY":"54","ENDT":"2015-08-12","ENDY":"54","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-022","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-20","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-28","STDY":"375","ENDT":"2016-06-28","ENDY":"375","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-023","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-12-27","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-11-21","STDY":"331","ENDT":"2016-12-03","ENDY":"343","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-023","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-12-27","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-07","STDY":"133","ENDT":"2016-07-27","ENDY":"214","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-023","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-12-27","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-27","STDY":"1","ENDT":"2015-12-27","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-023","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-12-27","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-02-23","STDY":"59","ENDT":"2016-02-23","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-023","SITEID":"04","SITE":"Site 04","AGE":"54","SEX":"F","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-12-27","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2017-01-03","STDY":"374","ENDT":"2017-01-03","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-024","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-08-27","STDY":"329","ENDT":"2016-09-14","ENDY":"347","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-024","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-04","STDY":"1","ENDT":"2015-10-04","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-024","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-02","STDY":"60","ENDT":"2015-12-02","ENDY":"60","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-024","SITEID":"04","SITE":"Site 04","AGE":"21","SEX":"M","RACE":"Hispanic","ARM":"Treatment A","RFSTDTC":"2015-10-04","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-04","STDY":"367","ENDT":"2016-10-04","ENDY":"367","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-025","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-05","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-24","STDY":"112","ENDT":"2016-05-01","ENDY":"363","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-025","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-05","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-10","STDY":"251","ENDT":"2016-04-14","ENDY":"346","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-025","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-05","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-20","STDY":"321","ENDT":"2016-03-20","ENDY":"321","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-025","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-05","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-09","STDY":"66","ENDT":"2015-08-13","ENDY":"101","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-025","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-05","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-05","STDY":"1","ENDT":"2015-05-05","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-025","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-05","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-28","STDY":"55","ENDT":"2015-06-28","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-025","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-05-05","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-26","STDY":"358","ENDT":"2016-04-26","ENDY":"358","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-026","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-08-08","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-30","STDY":"84","ENDT":"2016-03-31","ENDY":"237","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-026","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-08-08","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-30","STDY":"176","ENDT":"2016-05-11","ENDY":"278","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-026","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-08-08","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-10","STDY":"216","ENDT":"2016-06-20","ENDY":"318","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-026","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-08-08","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-08-08","STDY":"1","ENDT":"2015-08-08","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-026","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-08-08","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-05","STDY":"59","ENDT":"2015-10-05","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-026","SITEID":"04","SITE":"Site 04","AGE":"26","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-08-08","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-08-02","STDY":"361","ENDT":"2016-08-02","ENDY":"361","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-027","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-07-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-09-12","STDY":"72","ENDT":"2016-01-21","ENDY":"203","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-027","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-07-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-05","STDY":"278","ENDT":"2016-05-04","ENDY":"307","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-027","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-07-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-06","STDY":"340","ENDT":"2016-06-29","ENDY":"363","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-027","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-07-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-06","STDY":"35","ENDT":"2015-09-15","ENDY":"75","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-027","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-07-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-12","STDY":"102","ENDT":"2015-11-02","ENDY":"123","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-027","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-07-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-28","STDY":"118","ENDT":"2015-11-19","ENDY":"140","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-027","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-07-03","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-07-03","STDY":"1","ENDT":"2015-07-03","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-027","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-07-03","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-29","STDY":"58","ENDT":"2015-08-29","ENDY":"58","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-027","SITEID":"04","SITE":"Site 04","AGE":"27","SEX":"M","RACE":"Other/Mixed","ARM":"Placebo","RFSTDTC":"2015-07-03","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-07-09","STDY":"373","ENDT":"2016-07-09","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-028","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-01-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-02-08","STDY":"26","ENDT":"2015-11-01","ENDY":"292","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-028","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-01-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-14","STDY":"1","ENDT":"2015-01-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-028","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-01-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-03-08","STDY":"54","ENDT":"2015-03-08","ENDY":"54","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-028","SITEID":"04","SITE":"Site 04","AGE":"28","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-01-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-21","STDY":"373","ENDT":"2016-01-21","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-03-13","STDY":"49","ENDT":"2015-06-02","ENDY":"130","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-04","STDY":"132","ENDT":"2015-10-07","ENDY":"257","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-24","STDY":"182","ENDT":"2015-08-12","ENDY":"201","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-08","STDY":"197","ENDT":"2015-10-01","ENDY":"251","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-29","STDY":"310","ENDT":"2016-01-18","ENDY":"360","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-28","STDY":"95","ENDT":"2015-12-30","ENDY":"341","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-17","STDY":"359","ENDT":"2016-01-23","ENDY":"365","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-24","STDY":"1","ENDT":"2015-01-24","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-03-25","STDY":"61","ENDT":"2015-03-25","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-029","SITEID":"04","SITE":"Site 04","AGE":"51","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-24","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-20","STDY":"362","ENDT":"2016-01-20","ENDY":"362","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-19","STDY":"4","ENDT":"2015-10-20","ENDY":"127","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-23","STDY":"38","ENDT":"2015-08-03","ENDY":"49","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-23","STDY":"69","ENDT":"2015-11-10","ENDY":"148","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-04","STDY":"142","ENDT":"2015-12-08","ENDY":"176","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-26","STDY":"103","ENDT":"2016-02-08","ENDY":"238","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-10","STDY":"240","ENDT":"2016-02-13","ENDY":"243","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-06","STDY":"265","ENDT":"2016-04-22","ENDY":"312","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-16","STDY":"1","ENDT":"2015-06-16","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-06","STDY":"52","ENDT":"2015-08-06","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"04-030","SITEID":"04","SITE":"Site 04","AGE":"42","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-06-16","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-20","STDY":"371","ENDT":"2016-06-20","ENDY":"371","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-02-08","STDY":"3","ENDT":"2015-05-30","ENDY":"114","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-09","STDY":"124","ENDT":"2015-10-21","ENDY":"258","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-12","STDY":"127","ENDT":"2015-07-01","ENDY":"146","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-21","STDY":"136","ENDT":"2015-12-12","ENDY":"310","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-06-28","STDY":"143","ENDT":"2015-12-24","ENDY":"322","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-07","STDY":"244","ENDT":"2015-10-30","ENDY":"267","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-08","STDY":"337","ENDT":"2016-01-26","ENDY":"355","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-10","STDY":"339","ENDT":"2016-01-11","ENDY":"340","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-02-06","STDY":"1","ENDT":"2015-02-06","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-05","STDY":"59","ENDT":"2015-04-05","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-001","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"F","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-02-06","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-30","STDY":"359","ENDT":"2016-01-30","ENDY":"359","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-002","SITEID":"05","SITE":"Site 05","AGE":"18","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-10-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-30","STDY":"84","ENDT":"2016-03-23","ENDY":"168","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-002","SITEID":"05","SITE":"Site 05","AGE":"18","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-10-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-26","STDY":"202","ENDT":"2016-09-03","ENDY":"332","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-002","SITEID":"05","SITE":"Site 05","AGE":"18","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-10-08","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-14","STDY":"251","ENDT":"2016-07-16","ENDY":"283","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-002","SITEID":"05","SITE":"Site 05","AGE":"18","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-10-08","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-08","STDY":"1","ENDT":"2015-10-08","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-002","SITEID":"05","SITE":"Site 05","AGE":"18","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-10-08","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-05","STDY":"59","ENDT":"2015-12-05","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-002","SITEID":"05","SITE":"Site 05","AGE":"18","SEX":"M","RACE":"White","ARM":"Treatment B","RFSTDTC":"2015-10-08","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-11","STDY":"370","ENDT":"2016-10-11","ENDY":"370","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-003","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-23","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-05-06","STDY":"14","ENDT":"2015-12-08","ENDY":"230","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-003","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-23","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-29","STDY":"129","ENDT":"2015-11-07","ENDY":"199","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-003","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-23","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-31","STDY":"131","ENDT":"2015-10-14","ENDY":"175","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-003","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-23","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-05","STDY":"136","ENDT":"2015-10-23","ENDY":"184","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-003","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-23","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-10-30","STDY":"191","ENDT":"2015-11-20","ENDY":"212","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-003","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-23","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-23","STDY":"1","ENDT":"2015-04-23","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-003","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-23","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-13","STDY":"52","ENDT":"2015-06-13","ENDY":"52","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-003","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"F","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-04-23","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-27","STDY":"371","ENDT":"2016-04-27","ENDY":"371","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-004","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-12","STDY":"129","ENDT":"2016-04-23","ENDY":"140","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-004","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-06","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-07-10","STDY":"218","ENDT":"2016-07-11","ENDY":"219","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-004","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-10-02","STDY":"302","ENDT":"2016-10-15","ENDY":"315","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-004","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-06","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-10-18","STDY":"318","ENDT":"2016-11-24","ENDY":"355","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-004","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-06","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-06","STDY":"1","ENDT":"2015-12-06","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-004","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-06","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-24","STDY":"50","ENDT":"2016-01-24","ENDY":"50","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-004","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"F","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-12-06","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-12-02","STDY":"363","ENDT":"2016-12-02","ENDY":"363","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-005","SITEID":"05","SITE":"Site 05","AGE":"47","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-04","STDY":"158","ENDT":"2016-08-31","ENDY":"307","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-005","SITEID":"05","SITE":"Site 05","AGE":"47","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-25","STDY":"240","ENDT":"2016-10-15","ENDY":"352","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-005","SITEID":"05","SITE":"Site 05","AGE":"47","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-30","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-09-06","STDY":"313","ENDT":"2016-09-21","ENDY":"328","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-005","SITEID":"05","SITE":"Site 05","AGE":"47","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-13","STDY":"45","ENDT":"2016-06-17","ENDY":"232","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-005","SITEID":"05","SITE":"Site 05","AGE":"47","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-30","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-01","STDY":"216","ENDT":"2016-08-19","ENDY":"295","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-005","SITEID":"05","SITE":"Site 05","AGE":"47","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-30","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-30","STDY":"1","ENDT":"2015-10-30","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-005","SITEID":"05","SITE":"Site 05","AGE":"47","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-30","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-30","STDY":"62","ENDT":"2015-12-30","ENDY":"62","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-005","SITEID":"05","SITE":"Site 05","AGE":"47","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-30","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-01","STDY":"369","ENDT":"2016-11-01","ENDY":"369","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-05-07","STDY":"13","ENDT":"2015-07-13","ENDY":"80","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-11","STDY":"48","ENDT":"2015-12-07","ENDY":"227","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-23","STDY":"182","ENDT":"2016-01-03","ENDY":"254","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-15","STDY":"326","ENDT":"2016-03-30","ENDY":"341","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-04-25","STDY":"1","ENDT":"2015-11-11","ENDY":"201","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-05-11","STDY":"17","ENDT":"2015-11-27","ENDY":"217","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-15","STDY":"144","ENDT":"2015-10-03","ENDY":"162","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-16","STDY":"327","ENDT":"2016-04-07","ENDY":"349","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-25","STDY":"1","ENDT":"2015-04-25","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-20","STDY":"57","ENDT":"2015-06-20","ENDY":"57","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-006","SITEID":"05","SITE":"Site 05","AGE":"31","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-25","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-01","STDY":"373","ENDT":"2016-05-01","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-007","SITEID":"05","SITE":"Site 05","AGE":"21","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-10-15","SAFFL":"N","DOMAIN":"Enrollment","STDT":"2015-10-15","STDY":"1","ENDT":"2015-10-15","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-008","SITEID":"05","SITE":"Site 05","AGE":"21","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-15","STDY":"4","ENDT":"2015-12-13","ENDY":"32","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-008","SITEID":"05","SITE":"Site 05","AGE":"21","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-02","STDY":"143","ENDT":"2016-07-05","ENDY":"237","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-008","SITEID":"05","SITE":"Site 05","AGE":"21","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-08-23","STDY":"286","ENDT":"2016-10-16","ENDY":"340","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-008","SITEID":"05","SITE":"Site 05","AGE":"21","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-11-09","STDY":"364","ENDT":"2016-11-10","ENDY":"365","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-008","SITEID":"05","SITE":"Site 05","AGE":"21","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-27","STDY":"168","ENDT":"2016-08-28","ENDY":"291","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-008","SITEID":"05","SITE":"Site 05","AGE":"21","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-12","STDY":"1","ENDT":"2015-11-12","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-008","SITEID":"05","SITE":"Site 05","AGE":"21","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-03","STDY":"53","ENDT":"2016-01-03","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-008","SITEID":"05","SITE":"Site 05","AGE":"21","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-12","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-02","STDY":"357","ENDT":"2016-11-02","ENDY":"357","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-009","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-03","STDY":"160","ENDT":"2016-09-14","ENDY":"294","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-009","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-04","STDY":"161","ENDT":"2016-06-10","ENDY":"198","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-009","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-07","STDY":"134","ENDT":"2016-05-19","ENDY":"176","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-009","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-26","STDY":"1","ENDT":"2015-11-26","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-009","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-20","STDY":"56","ENDT":"2016-01-20","ENDY":"56","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-009","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"F","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-11-26","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-12-03","STDY":"374","ENDT":"2016-12-03","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-010","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-26","STDY":"10","ENDT":"2016-07-31","ENDY":"228","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-010","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-23","STDY":"98","ENDT":"2016-03-30","ENDY":"105","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-010","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-17","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-07-16","STDY":"213","ENDT":"2016-09-01","ENDY":"260","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-010","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-17","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-17","STDY":"1","ENDT":"2015-12-17","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-010","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-17","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-02-13","STDY":"59","ENDT":"2016-02-13","ENDY":"59","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-010","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-12-17","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-12-08","STDY":"358","ENDT":"2016-12-08","ENDY":"358","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-23","STDY":"8","ENDT":"2016-08-25","ENDY":"284","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-24","STDY":"161","ENDT":"2016-06-04","ENDY":"202","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-19","STDY":"217","ENDT":"2016-08-27","ENDY":"286","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-08-23","STDY":"282","ENDT":"2016-08-27","ENDY":"286","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-10-16","STDY":"336","ENDT":"2016-10-17","ENDY":"337","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-02-14","STDY":"91","ENDT":"2016-05-25","ENDY":"192","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-11","STDY":"209","ENDT":"2016-08-15","ENDY":"274","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-07-04","STDY":"232","ENDT":"2016-11-02","ENDY":"353","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-10-15","STDY":"335","ENDT":"2016-11-13","ENDY":"364","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-11-09","STDY":"360","ENDT":"2016-11-10","ENDY":"361","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-16","STDY":"1","ENDT":"2015-11-16","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-10","STDY":"56","ENDT":"2016-01-10","ENDY":"56","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-011","SITEID":"05","SITE":"Site 05","AGE":"43","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-11-16","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-19","STDY":"370","ENDT":"2016-11-19","ENDY":"370","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-04","STDY":"185","ENDT":"2016-03-25","ENDY":"297","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-17","STDY":"198","ENDT":"2015-12-21","ENDY":"202","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-25","STDY":"237","ENDT":"2016-03-20","ENDY":"292","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-31","STDY":"303","ENDT":"2016-05-27","ENDY":"360","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-04","STDY":"307","ENDT":"2016-04-06","ENDY":"309","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-03","STDY":"306","ENDT":"2016-04-30","ENDY":"333","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-13","STDY":"346","ENDT":"2016-05-15","ENDY":"348","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-06-03","STDY":"1","ENDT":"2015-06-03","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-25","STDY":"53","ENDT":"2015-07-25","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-012","SITEID":"05","SITE":"Site 05","AGE":"26","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-06-03","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-01","STDY":"365","ENDT":"2016-06-01","ENDY":"365","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-013","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-18","STDY":"91","ENDT":"2016-01-30","ENDY":"287","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-013","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-02","STDY":"198","ENDT":"2016-01-07","ENDY":"264","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-013","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-05","STDY":"262","ENDT":"2016-04-14","ENDY":"362","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-013","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-06-15","STDY":"58","ENDT":"2015-08-27","ENDY":"131","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-013","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-09-29","STDY":"164","ENDT":"2016-01-14","ENDY":"271","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-013","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-19","STDY":"1","ENDT":"2015-04-19","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-013","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-14","STDY":"57","ENDT":"2015-06-14","ENDY":"57","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-013","SITEID":"05","SITE":"Site 05","AGE":"45","SEX":"M","RACE":"Black","ARM":"Treatment A","RFSTDTC":"2015-04-19","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-26","STDY":"374","ENDT":"2016-04-26","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-014","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-12","STDY":"139","ENDT":"2016-05-01","ENDY":"189","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-014","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-23","STDY":"181","ENDT":"2016-10-23","ENDY":"364","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-014","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-26","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-26","STDY":"1","ENDT":"2015-10-26","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-014","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-26","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-25","STDY":"61","ENDT":"2015-12-25","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-014","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-26","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-31","STDY":"372","ENDT":"2016-10-31","ENDY":"372","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-015","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-27","STDY":"43","ENDT":"2016-03-08","ENDY":"145","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-015","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-19","STDY":"65","ENDT":"2016-02-04","ENDY":"112","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-015","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-17","STDY":"125","ENDT":"2016-06-27","ENDY":"256","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-015","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-04","STDY":"20","ENDT":"2016-06-19","ENDY":"248","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-015","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-06-04","STDY":"233","ENDT":"2016-06-23","ENDY":"252","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-015","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-16","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-16","STDY":"1","ENDT":"2015-10-16","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-015","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-16","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-16","STDY":"62","ENDT":"2015-12-16","ENDY":"62","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-015","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment B","RFSTDTC":"2015-10-16","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-06","STDY":"357","ENDT":"2016-10-06","ENDY":"357","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-016","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-07","STDY":"36","ENDT":"2016-04-12","ENDY":"193","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-016","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-02","STDY":"92","ENDT":"2016-07-12","ENDY":"284","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-016","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-16","STDY":"197","ENDT":"2016-09-06","ENDY":"340","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-016","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-03","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-18","STDY":"260","ENDT":"2016-07-12","ENDY":"284","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-016","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-03","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-03","STDY":"1","ENDT":"2015-10-03","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-016","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-03","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-12-04","STDY":"63","ENDT":"2015-12-04","ENDY":"63","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-016","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Treatment B","RFSTDTC":"2015-10-03","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-10-08","STDY":"372","ENDT":"2016-10-08","ENDY":"372","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-017","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-04-29","STDY":"82","ENDT":"2015-12-27","ENDY":"324","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-017","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-31","STDY":"175","ENDT":"2015-12-06","ENDY":"303","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-017","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-09-24","STDY":"230","ENDT":"2015-10-27","ENDY":"263","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-017","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-19","STDY":"347","ENDT":"2016-02-05","ENDY":"364","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-017","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-02-07","STDY":"1","ENDT":"2015-02-07","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-017","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-03-27","STDY":"49","ENDT":"2015-03-27","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-017","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-02-07","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-10","STDY":"369","ENDT":"2016-02-10","ENDY":"369","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-018","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-07-04","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-06-12","STDY":"345","ENDT":"2016-06-27","ENDY":"360","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-018","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-07-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-11-06","STDY":"126","ENDT":"2016-01-15","ENDY":"196","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-018","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-07-04","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-08","STDY":"310","ENDT":"2016-06-18","ENDY":"351","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-018","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-07-04","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-07-04","STDY":"1","ENDT":"2015-07-04","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-018","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-07-04","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-08-26","STDY":"54","ENDT":"2015-08-26","ENDY":"54","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-018","SITEID":"05","SITE":"Site 05","AGE":"40","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-07-04","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-06-28","STDY":"361","ENDT":"2016-06-28","ENDY":"361","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-019","SITEID":"05","SITE":"Site 05","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-07","STDY":"116","ENDT":"2016-05-08","ENDY":"147","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-019","SITEID":"05","SITE":"Site 05","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-19","STDY":"6","ENDT":"2016-05-22","ENDY":"161","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-019","SITEID":"05","SITE":"Site 05","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-05","STDY":"23","ENDT":"2016-06-26","ENDY":"196","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-019","SITEID":"05","SITE":"Site 05","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-28","STDY":"167","ENDT":"2016-12-06","ENDY":"359","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-019","SITEID":"05","SITE":"Site 05","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-09-28","STDY":"290","ENDT":"2016-11-09","ENDY":"332","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-019","SITEID":"05","SITE":"Site 05","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-10-25","STDY":"317","ENDT":"2016-11-22","ENDY":"345","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-019","SITEID":"05","SITE":"Site 05","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-14","STDY":"1","ENDT":"2015-12-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-019","SITEID":"05","SITE":"Site 05","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-02-06","STDY":"55","ENDT":"2016-02-06","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-019","SITEID":"05","SITE":"Site 05","AGE":"36","SEX":"F","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-12-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-12-11","STDY":"364","ENDT":"2016-12-11","ENDY":"364","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-02","STDY":"142","ENDT":"2015-11-03","ENDY":"174","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-21","STDY":"161","ENDT":"2015-11-17","ENDY":"188","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-17","STDY":"218","ENDT":"2016-05-01","ENDY":"354","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-19","STDY":"251","ENDT":"2016-03-30","ENDY":"322","SEQ":"4","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-03","STDY":"266","ENDT":"2016-03-28","ENDY":"320","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-05-23","STDY":"10","ENDT":"2015-10-10","ENDY":"150","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-19","STDY":"220","ENDT":"2016-02-26","ENDY":"289","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-12","STDY":"304","ENDT":"2016-04-06","ENDY":"329","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-05-14","STDY":"1","ENDT":"2015-05-14","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-07-07","STDY":"55","ENDT":"2015-07-07","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-020","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-05-14","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-05-22","STDY":"375","ENDT":"2016-05-22","ENDY":"375","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-021","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-04","STDY":"106","ENDT":"2015-08-12","ENDY":"114","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-021","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-21","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-28","STDY":"130","ENDT":"2016-01-21","ENDY":"276","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-021","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-05-07","STDY":"17","ENDT":"2015-12-06","ENDY":"230","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-021","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-08-27","STDY":"129","ENDT":"2015-11-19","ENDY":"213","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-021","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-12-19","STDY":"243","ENDT":"2016-04-19","ENDY":"365","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-021","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-21","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-16","STDY":"271","ENDT":"2016-04-17","ENDY":"363","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-021","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-21","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-21","STDY":"1","ENDT":"2015-04-21","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-021","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-21","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-14","STDY":"55","ENDT":"2015-06-14","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-021","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-04-21","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-15","STDY":"361","ENDT":"2016-04-15","ENDY":"361","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-022","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-15","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-11","STDY":"88","ENDT":"2016-04-01","ENDY":"353","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-022","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-15","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-24","STDY":"101","ENDT":"2015-08-29","ENDY":"137","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-022","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-15","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-12-28","STDY":"258","ENDT":"2016-01-31","ENDY":"292","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-022","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-15","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-15","STDY":"1","ENDT":"2015-04-15","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-022","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-15","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-09","STDY":"56","ENDT":"2015-06-09","ENDY":"56","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-022","SITEID":"05","SITE":"Site 05","AGE":"24","SEX":"M","RACE":"Hispanic","ARM":"Treatment B","RFSTDTC":"2015-04-15","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-23","STDY":"375","ENDT":"2016-04-23","ENDY":"375","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-023","SITEID":"05","SITE":"Site 05","AGE":"29","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-11","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-05-27","STDY":"137","ENDT":"2015-07-20","ENDY":"191","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-023","SITEID":"05","SITE":"Site 05","AGE":"29","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-11","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-06-26","STDY":"167","ENDT":"2015-06-27","ENDY":"168","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-023","SITEID":"05","SITE":"Site 05","AGE":"29","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-11","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-11","STDY":"182","ENDT":"2015-10-13","ENDY":"276","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-023","SITEID":"05","SITE":"Site 05","AGE":"29","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-11","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-11","STDY":"1","ENDT":"2015-01-11","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-023","SITEID":"05","SITE":"Site 05","AGE":"29","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-11","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-02-28","STDY":"49","ENDT":"2015-02-28","ENDY":"49","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-023","SITEID":"05","SITE":"Site 05","AGE":"29","SEX":"F","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-11","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-19","STDY":"374","ENDT":"2016-01-19","ENDY":"374","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-024","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-07-07","STDY":"83","ENDT":"2015-08-17","ENDY":"124","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-024","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-08","STDY":"328","ENDT":"2016-04-11","ENDY":"362","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-024","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-16","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-17","STDY":"337","ENDT":"2016-04-05","ENDY":"356","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-024","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-09","STDY":"269","ENDT":"2016-04-05","ENDY":"356","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-024","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-16","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-08","STDY":"328","ENDT":"2016-04-06","ENDY":"357","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-024","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-16","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-04-16","STDY":"1","ENDT":"2015-04-16","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-024","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-16","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-06-07","STDY":"53","ENDT":"2015-06-07","ENDY":"53","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-024","SITEID":"05","SITE":"Site 05","AGE":"48","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-04-16","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-04-13","STDY":"364","ENDT":"2016-04-13","ENDY":"364","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-025","SITEID":"05","SITE":"Site 05","AGE":"50","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-08-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-09-02","STDY":"24","ENDT":"2016-04-10","ENDY":"245","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-025","SITEID":"05","SITE":"Site 05","AGE":"50","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-08-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-20","STDY":"103","ENDT":"2016-04-19","ENDY":"254","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-025","SITEID":"05","SITE":"Site 05","AGE":"50","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-08-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-28","STDY":"111","ENDT":"2016-07-25","ENDY":"351","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-025","SITEID":"05","SITE":"Site 05","AGE":"50","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-08-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-05","STDY":"149","ENDT":"2016-04-19","ENDY":"254","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-025","SITEID":"05","SITE":"Site 05","AGE":"50","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-08-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-11","STDY":"246","ENDT":"2016-07-18","ENDY":"344","SEQ":"5","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-025","SITEID":"05","SITE":"Site 05","AGE":"50","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-08-10","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-08-10","STDY":"1","ENDT":"2015-08-10","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-025","SITEID":"05","SITE":"Site 05","AGE":"50","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-08-10","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-10-03","STDY":"55","ENDT":"2015-10-03","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-025","SITEID":"05","SITE":"Site 05","AGE":"50","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-08-10","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-08-18","STDY":"375","ENDT":"2016-08-18","ENDY":"375","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-026","SITEID":"05","SITE":"Site 05","AGE":"41","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-11-10","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-04-27","STDY":"170","ENDT":"2016-07-05","ENDY":"239","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-026","SITEID":"05","SITE":"Site 05","AGE":"41","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-11-10","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-02","STDY":"54","ENDT":"2016-06-08","ENDY":"212","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-026","SITEID":"05","SITE":"Site 05","AGE":"41","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-11-10","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-08","STDY":"60","ENDT":"2016-05-25","ENDY":"198","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-026","SITEID":"05","SITE":"Site 05","AGE":"41","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-11-10","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-03-13","STDY":"125","ENDT":"2016-11-07","ENDY":"364","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-026","SITEID":"05","SITE":"Site 05","AGE":"41","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-11-10","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-11","STDY":"154","ENDT":"2016-07-06","ENDY":"240","SEQ":"4","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-026","SITEID":"05","SITE":"Site 05","AGE":"41","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-11-10","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-04-25","STDY":"168","ENDT":"2016-08-16","ENDY":"281","SEQ":"5","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-026","SITEID":"05","SITE":"Site 05","AGE":"41","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-11-10","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-11-10","STDY":"1","ENDT":"2015-11-10","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-026","SITEID":"05","SITE":"Site 05","AGE":"41","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-11-10","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-05","STDY":"57","ENDT":"2016-01-05","ENDY":"57","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-026","SITEID":"05","SITE":"Site 05","AGE":"41","SEX":"M","RACE":"Hispanic","ARM":"Placebo","RFSTDTC":"2015-11-10","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-11-09","STDY":"366","ENDT":"2016-11-09","ENDY":"366","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-027","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-01","STDY":"127","ENDT":"2015-12-13","ENDY":"322","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-027","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-08-24","STDY":"211","ENDT":"2015-10-08","ENDY":"256","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-027","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-26","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-10-15","STDY":"263","ENDT":"2016-01-06","ENDY":"346","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-027","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-02-09","STDY":"15","ENDT":"2015-03-08","ENDY":"42","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-027","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2015-07-04","STDY":"160","ENDT":"2015-12-01","ENDY":"310","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-027","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-26","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-01-01","STDY":"341","ENDT":"2016-01-14","ENDY":"354","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-027","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-26","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-01-26","STDY":"1","ENDT":"2015-01-26","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-027","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-26","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-03-21","STDY":"55","ENDT":"2015-03-21","ENDY":"55","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-027","SITEID":"05","SITE":"Site 05","AGE":"32","SEX":"M","RACE":"Black","ARM":"Placebo","RFSTDTC":"2015-01-26","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-01-25","STDY":"365","ENDT":"2016-01-25","ENDY":"365","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-028","SITEID":"05","SITE":"Site 05","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-06-09","STDY":"101","ENDT":"2016-02-22","ENDY":"359","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-028","SITEID":"05","SITE":"Site 05","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2015-11-03","STDY":"248","ENDT":"2016-02-11","ENDY":"348","SEQ":"2","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-028","SITEID":"05","SITE":"Site 05","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-01-12","STDY":"318","ENDT":"2016-02-25","ENDY":"362","SEQ":"3","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-028","SITEID":"05","SITE":"Site 05","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-03-01","STDY":"1","ENDT":"2015-03-01","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-028","SITEID":"05","SITE":"Site 05","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-04-30","STDY":"61","ENDT":"2015-04-30","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-028","SITEID":"05","SITE":"Site 05","AGE":"54","SEX":"M","RACE":"White","ARM":"Treatment A","RFSTDTC":"2015-03-01","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-02-26","STDY":"363","ENDT":"2016-02-26","ENDY":"363","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-029","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-12-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-03","STDY":"93","ENDT":"2016-05-18","ENDY":"169","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-029","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-12-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-03-13","STDY":"103","ENDT":"2016-09-20","ENDY":"294","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-029","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-12-02","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-11","STDY":"162","ENDT":"2016-07-21","ENDY":"233","SEQ":"1","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-029","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-12-02","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-10-18","STDY":"322","ENDT":"2016-11-13","ENDY":"348","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-029","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-12-02","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-12-02","STDY":"1","ENDT":"2015-12-02","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-029","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-12-02","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2016-01-31","STDY":"61","ENDT":"2016-01-31","ENDY":"61","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-029","SITEID":"05","SITE":"Site 05","AGE":"42","SEX":"M","RACE":"Other/Mixed","ARM":"Treatment A","RFSTDTC":"2015-12-02","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-12-08","STDY":"373","ENDT":"2016-12-08","ENDY":"373","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"},{"USUBJID":"05-030","SITEID":"05","SITE":"Site 05","AGE":"35","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-07","STDY":"129","ENDT":"2016-02-16","ENDY":"138","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-030","SITEID":"05","SITE":"Site 05","AGE":"35","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-02-23","STDY":"145","ENDT":"2016-03-02","ENDY":"153","SEQ":"2","ONGO":"Y","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-030","SITEID":"05","SITE":"Site 05","AGE":"35","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Adverse Events","STDT":"2016-05-03","STDY":"215","ENDT":"2016-05-18","ENDY":"230","SEQ":"3","ONGO":"N","TOOLTIP":"This mark definitely represents the Adverse Events domain"},{"USUBJID":"05-030","SITEID":"05","SITE":"Site 05","AGE":"35","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Concomitant Medications","STDT":"2016-05-10","STDY":"222","ENDT":"2016-08-08","ENDY":"312","SEQ":"1","ONGO":"N","TOOLTIP":"This mark definitely represents the Concomitant Medications domain"},{"USUBJID":"05-030","SITEID":"05","SITE":"Site 05","AGE":"35","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Enrollment","STDT":"2015-10-02","STDY":"1","ENDT":"2015-10-02","ENDY":"1","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Enrollment domain"},{"USUBJID":"05-030","SITEID":"05","SITE":"Site 05","AGE":"35","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Randomization","STDT":"2015-11-30","STDY":"60","ENDT":"2015-11-30","ENDY":"60","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Randomization domain"},{"USUBJID":"05-030","SITEID":"05","SITE":"Site 05","AGE":"35","SEX":"M","RACE":"White","ARM":"Placebo","RFSTDTC":"2015-10-02","SAFFL":"Y","DOMAIN":"Study Completion","STDT":"2016-09-25","STDY":"360","ENDT":"2016-09-25","ENDY":"360","SEQ":"1","ONGO":"","TOOLTIP":"This mark definitely represents the Study Completion domain"}]
